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Abstract 
Cellular transplantation, a current therapy for cardiac failure, does not consider 
the need for a physical support or biochemical factors required by the 
cardiomyocyte. The aim of this project was to establish the Extra Cellular 
Matrix (ECM), architectural and mechanical properties of a flexible scaffold to 
assist the maintenance of a cardiac cell line cultured under mechanical stimuli. 
Previously, mechanical stimulation has been proved to have an effect in 
cardiomyocytes similar to that of growth factors on other cells and promotes 
protein expression, differentiation and survival [1]. Poly-( I ,8-octanediol-co-
citric acid) [POC] is an elastomer that can be processed into scaffolds for tissue 
engineering. Mechanical properties of the POC were compared at different 
porosity, storage method and strain rate. POC, with an ultimate elongation of 
60-160%, did support cardiac cell attachment when coated with fibronectin. 
Seeding strategies were evaluated to find optimal conditions and static seeding 
resulted more favourable for cell adhesion and survival than other dynamics 
approaches. In collaboration with the University of Leeds, cardiomyocytes 
were cultured in a dynamic bioreactor, Tencell, under continuous and 
discontinuous stretching regimes. Mechano-stimulation of cardiac constructs 
encouraged cell survival in the discontinuous regime and up-regulated the 
expression of acfci and nppa genes regardless of the treatments. It was 
concluded that although mechanical stimulation had a positive effect on cell 
survival and gene expression, tissue formation was not promoted. 
Keywords: Scaffold, Poly-(l,8-octanediol-co-citric acid) [POC] , Elastomer, 
Cardiomyocyte, Tissue Engineering. 
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hexamethyldisilazane 
haematopoietic stem cells 
Hertz 
Intelligent tissue engineering via mechanical stimulation 
kiloPascals 
kilovolts 
initial length of the material before a load is applied, 
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LV 
mA 
MHC 
mL 
MLC 
mm 
MPa 
mRNA 
ms 
MSC 
NASA 
PBS 
peL 
PDLA 
PE 
PEG 
PGA 
PGS 
pH 
PHEMA 
PLLA 
POC 
pp 
Psi 
PU 
left ventricle 
milliamperes 
myosin heavy chain 
millilitre 
myosin light chains 
millimetre 
Megapascals 
messenger ribonucleic acid 
milliseconds 
mesenchymal or bone-marrow stem cells 
National Aeronautics and Space Administration 
Phosphate Buffered Saline 
poly( caprolactone) 
poly(DL-lactic acid) 
Polyethylene 
Poly( ethylene glycol) 
poly(glycolic acid) 
poly(glycerol-sebacate) 
measure of acidity/alkalinity 
Poly(hydroxyethyl methacrylate) 
poly(L-lactic acid) 
Poly-( 1 ,8-octanediol-co-citric acid) 
Polypropylene 
pounds per square inch 
Polyurethanes 
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qRT-PCR 
RGD 
Rpm 
RT 
SA 
scC02 
SCPL 
sd 
SEM 
SEP 
SFF 
SLA 
STLV 
TCP 
TEFLON 
Tg 
T G F ~ ~
U 
UK 
USA 
UV 
V 
VEGF 
w 
YIGSR 
quantitative Reverse Transcriptase -Polymerase Chain Reaction 
arginine-glycine-aspartine 
revolutions per minute 
room temperature 
Sinoatrial 
supercritical carbon dioxide 
solvent casting and particle leaching 
standard deviation 
scanning electron microscopy 
Mexican Ministry of Education 
solid free-form fabrication 
stereo lithography 
slow turning lateral vessel 
tissue culture plastic 
poly-(tetrafluoroethylene) 
glass transition temperature 
Transforming Growth Factor beta 
Units 
United Kingdom 
United States of America 
ultraviolet 
volume 
vascular endothelial growth factor 
weight 
tyrosine-isoleucine-glycine-serine-arginine 
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1 Cardiac Diseases: Current Therapies and Research 
This first chapter presents the significance impact of heart diseases on 
healthcare systems and patient quality of life· Conventional therapies and new 
approaches to treat cardiac patients will be discussed It particularly focuses 
on the role of tissue engineering as an emerging clinical alternative and 
describes its key elements: cells, biomaterials and bioreactors. This literature 
review establishes the basis for this work; the main aim of which is to evaluate 
a mechanically stimulated 3D culture of cardiac cells contained with flexible 
structures. 
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1.1 Cardiac Diseases: Current Therapies and Research 
This work evolved as a consequence of the increasing number of deaths related 
to cardiac causes and the few alternatives available to cure these diseases; all 
these resulting in poor quality of life for patients and a significant cost to 
healthcare services. 
Regenerative medicine has re-emerged in recent years as one of the applied 
sciences with potential impact in daily life. However before testing any new 
therapy in patients, all the processes involved need to be optimised and run 
through several phases of clinical trials to ensure the safety and efficacy of the 
treatment. This work endeavours to contribute to the development of in vitro 
cardiomyocyte structures engineered under dynamic conditions by considering 
all the elements involved in such a task. 
1.2 Cardiac Diseases, Mortality and Morbidity 
The need for heart replacement therapies is evident in the increasing figures of 
morbidity and mortality due to heart disease in most Western countries, where 
this disease is the major cause of deaths. In Europe, cardiovascular disease 
(CVD) causes nearly half of all deaths, 47%, with cardiac diseases (coronary 
heart diseases and stroke) comprising 40% of CVD [1]. The prevalence of risk 
factors among the European population is increasing in such levels that 
projections for consequent years still consider CVD as the main cause of death 
and the most common chronic disease on this continent. 
In the United Kingdom, cardiovascular diseases were the most reported 
common cause of death with 260,000 deaths per annum (42%) in 2005 [2]. 
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Cardiac disease deaths are included in the latter statistic with an average 
number of deaths of 206,000 (32%) per year in England, Scotland, Ireland. and 
Wales and is the main cause of premature death. In addition, the population 
with some level of cardiac disease is currently 2.6 million people (4.5% of total 
population) who are in treatment to control or cure their condition [3]. 
In the United States of America (USA), the figures are similar to Europe with 
38% of deaths caused by heart disease and 43% of all cardiovascular causes. A 
history of a heart attack is held by 2.5% of Americans, whereas 22% of the 
American population suffers some kind of cardiovascular disease and 6% 
suffer from heart disease [4]. 
1.2.1 Cardiac Anatomy 
Structure And Function Of The Heart 
The cardiovascular system includes the heart, blood and blood vessels. The 
heart is a highly vascularised organ that weighs an average of 300-350 grams 
and contains 120 millilitres of blood in adult humans. It is well protected as it 
is flanked by the ribcage and protected by the breastbone, lungs, diaphragm 
and pericardium. The heart is essentially a muscle that pumps oxygenated or 
deoxygenated blood around the body including the lungs. The heart is formed 
by four chambers and four valves. Superior chambers are called atria and the 
inferior, ventricles (Figure 1-1). The muscle of the ventricle walls is thicker 
than those of the atria because of the high pressures required to be generated. 
The heart is not only a pump but also an endocrine organ: the myocardium has 
a stock of active natriuretic peptides (polypeptide hormones) that are released 
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Pulmonary 
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Inferior vena cava 
Figure 1-1 Diagram of the heart anatomy adapted from [5] 
Pulmonary 7 veins 
Left ventricle 
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during stretching of the atria and increased serum levels indicate cardiac 
hypertrophy [5]. 
Cellular Structure 
Cardiomyocytes are the contractile muscle cells of the heart and constitute 75% 
of this organ. The remaining organ is formed by blood vessels, pacemakers 
and conducting tissues, including fibroblasts. Cardiomyocytes are organised 
into structures called myofibres which are bound together by collagen to form 
the muscle tissue. 
The heart exterior is lined by epicardial cells over a matrix of fibro-elastic 
connective tissue, whereas the myocardium fibres that constitute the wall of the 
heart are contained between the endocardium and epicardium. There are three 
types of cardiac cells; each one is located in a different part of the heart and 
carries out different functions (see Table 1-1) [5]. The electrical and 
mechanical connection between cardiac cells is completed by intercalated 
disks. These cell-to-cell junctions are specialised and depending on each 
function, express different proteins (see Table 1-2). 
1.2.1.a.l Cardiomyocytes 
Cardiomyocytes (Figure 1-2) have an average diameter of 10-20 ~ m , , length of 
50-1 00 ~ m m and a single central nucleus. Each cell contains 100-150 thin 
sarcomere myofibrils composed of seven major proteins arranged in thin and 
thick filaments of actin, myosin heavy and light chains (MHC, MLC). 
tropomyosin and troponin proteins. The interaction of the myosin and actin that 
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Myocytes 
Purjinke 
fibres 
Nodal cells 
Atria and ventricles 
Atrioventricular CA V) bundle, 
branches and ventricular 
endocardium. 
Sinoatrial (SA) & AV nodes 
Contraction 
Rapid conduction 
with intercalated disks 
Pacemaker activity 
and atrioventricular 
conduction 
Table 1-1 Location and function of the different types of cells present in the heart 151 
Electrical 
Gap Conexin 43 (Cx43) 
communication 
Fascia adherence Mechanical linkage Actin and a-actin 
Electrical 
Desmosome Desmin 
communication 
Table 1-2 Function and protein involved in typical cardiac junctions (51 
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Figure 1-2 Phase contrast image of "L-l cardiomyocytes at lower magnification (lOx) 
shows phenotypical elongated morphology 
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induces contraction is controlled by the intracellular calcium concentration. 
The orientation of the myofibrils is important for the conduction of the 
electrical wave. Around the left ventricle (LV) the myofibrils are arranged in a 
circumferential direction whilst the myofibrils within the other regions of the 
heart are arranged in a longitudinal orientation. The shortening of these 
myofibrils result in the contraction of heart chambers. Cardiomyocytes differ 
depending on if they are ventricular or atrial. As reported above, substantial 
differences lie between ventricular and atrial structure and functions; atrial and 
ventricular myocyte characteristics are reported in Table 1-3 [5]. 
1.2.1.a.2 Electrical Coupling and Contraction 
Electrical coupling occurs via a calcium biochemical pathway. Calcium-
Induced, Calcium-Released (CICR) channels transport the calcium influx. 
High levels of intra-cellular calcium induce myosin-actin contact, decreasing 
sarcomere length and producing a contraction. This transport requires energy, 
which is supplied by adenosine tri-phosphate (A TP) molecules. When calcium 
returns to the sarcoplasmic reticulum it triggers a sodium-calcium channel that 
decreases calcium levels resulting in myocardial relaxation. The contractile 
process is mainly controlled by the proteins myosin, actin, tropomyosin and 
troponin C, I and T [6]. Diastole and systole are common terms in the medical 
field, the first is related to cardiac relaxation and the second one to cardiac 
contraction [7,8]. 
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Shape Long and narrow Elliptical 
Length ( ~ m ) ) 50-100 About 20 
Diameter ( ~ m ) ) 10-25 5-6 
T tubules Plentiful Rare or none 
Intercalated disk Prominent end-to-end Side-to-side and end-to-
and gap junction 
General 
appearance 
transmission end transmission 
Mitochondria and 
sarcomeres, very abundant; Bundles of atrial tissue 
rectangular branching separated by wide areas 
bundles with little interstitial of collagen 
collagen 
Table 1-3 Comparison of characteristics between atrial and ventricular cardiomyocytes 
IS) 
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Heart contraction is due to electrical impulses generated and conducted along 
the muscle. The sequence of these events determines the normal behaviour of 
the heart. The electrical signal is activated spontaneously; some zones are 
polarised whilst others depolarised. The waves are propagated first to the right 
atrium, then to the left atrium, and after that to the ventricles. 
1.2.2 Diseases 
The most common heart disease is heart failure which denotes a weak 
contractile function of the heart because of a blocked vessel. This blockage 
decreases the pump ability and therefore the oxygen supply to the body, 
including the heart. This leads to a myocardial infarction which is the death of 
part of the cardiac muscle because of this lack of oxygen [4]. 
Other less common diseases are endocarditis or inflammation of the inside of 
the heart cavities or heart valves, and congenital heart diseases (CHD), caused 
by abnormal heart development during pregnancy, that affects the structure and 
function of the heart. 
In order to gain an accurate diagnosis, multiple tests must be performed on 
each patient, such as physical examination (irregular heartbeat, heart sounds, 
breath sounds), coronary angiography, echocardiogram, chest X-ray, chest 
computed tomography (CT) scan, electrocardiogram (ECG), heart biopsy and 
lab tests (complete blood count, coronary risk profile, blood chemistries and 
cardiac enzymes), because of the wide range of symptoms. These diagnostic 
tests as well as the therapy result in a high cost to the health services, moreover 
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the low long-term effectiveness of these therapies represents a national health 
issue [4]. 
1.3 Cardiac Regeneration & Treatments 
1.3.1 The Challenge of Cardiac Regeneration 
Researchers believe that cell regeneration will vary depending on the type of 
cellular death. Necrosis induces an inflammatory response, collagen 
deposition for scar tissue and fibroblast activation whilst apoptosis does not 
[9]. Adult mammalian cardiac tissue cannot regenerate. Cardiomyocyte 
proliferation starts decreasing from birth and they are not able to re-enter the 
cell cycle again after an injury [to]. After cardiomyocyte death, non 
contractile scar tissue (formed of collagen fibrils) replaces the cardiac muscle 
along with hardening of the damaged myocardium. This initial damage and 
subsequent remodelling of the heart tissue starts with chained cellular events 
that lead to heart failure. This failure is caused by the inability of the organ to 
pump blood with a normal cardiac output and therefore fulfil the body's 
requirements of nutrients and oxygen [11]. Some researchers have reported 
spontaneous cardiac regeneration after a myocardial infarction carried out by 
myofibroblasts. However, these fibroblast-like contractile cells do not achieve 
total regeneration of the damaged tissue [12, 13]. For a functional recovery 
after ischemia, there is a need to incorporate functional cardiomyocytes and 
paracrine factors. This will cue the repair mechanism, limit the scar tissue and 
improve the vascularisation through angiogenesis, inducing the formation of 
new capillaries and vessels [14]. 
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1.3.2 Available Treatments 
The treatments for heart disease depend on several factors: cause, age, risks 
and the clinical history of each patient. A vailable treatments include 
medication, dietary and lifestyle changes, and surgery. However, current 
treatments are not effective for more than 2 years and only delay progression 
and congestive failure in most cases [4]. Cardiac transplantation, the best 
therapy available, is restricted by the shortage of donors, the risk of tissue 
rejection, infection and pathogen transfer, and the high cost of the complex 
long-term intensive care. 
Recent research has concentrated on three mam strategies: cellular 
transplantation, tissue replacement and tissue regeneration. Cardiomyoplasty 
could potentially improve outcomes both in terms of morbidity and mortality. 
This therapy involves transplanting different kind of cells and tissues into the 
affected zone [15]. Strategies for this repopulation include direct 
transplantation of cells, mobilisation of endogenous stem cells to the damaged 
area and initiation of the cardiomyocyte cell cycle in the surviving cells. In 
cellular cardiomyoplasty, different sources of cells have been tried in order to 
improve heart performance following infarction [16]. These include primary 
cells such as adult cardiomyocytes, smooth muscle cells, skeletal myoblasts 
and fibroblasts. Stem cells are a novel source that includes specific adult stem 
cells (SC), mesenchymal or bone-marrow stem cells (MSC), circulating or 
haematopoietic stem cells (HSC) and embryonic stem cells (ESC). In the case 
of the latter, some concerns have arisen regarding the risk of ES-derived 
tumours and arrhythmias following transplantation [17]. 
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The most important characteristic for a suitable cell type for cellular therapies 
is the ability to differentiate into a specific and functional cardiac cell but also 
to couple physically, as well as electrically, to the host tissue in order to 
develop synchronic contractions. Research in cardiac muscle repair has been 
focused on two alternatives, cellular transplantation and cardiac tissue 
engineered grafts. In the last ten years several pre-cIinical and clinical phase I 
and 11 trials of cell transplantation have been conducted in cardiac patients, 
including direct injection or percutaneous application of myoblasts derived 
from skeletal muscle satellite cells, stem cell-derived cardiomyocytes, skeletal 
ventricle muscle and tissular wraps [18]. Most of the reports, generated from 
European and American studies, indicate that cellular cardiomyoplasty is an 
easy and effective therapy for cardiac failure [19]. Some researchers have 
started phase I clinical trials to show the feasibility of intracardiac autologous 
skeletal myoblast implantation in humans with good results. Clinical data 
showed an improvement in the contractile function when the transplantation 
was combined with a bypass procedure [20]. Food and Drugs Administration 
(FDA) approval has been granted to Bioheart Inc. to practice this therapy. 
More than 450 patients have taken this option without further complications 
although long-term results are still missing to determine its complete 
success[21] . 
Tissular cardiomyoplasties have not been assessed to the same extent as 
cellular. The main limitation is the limited range of patients suitable for this 
procedure, mainly in early stages ofCHF [22]. 
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Tissue regeneration aims to prompt biochemical and physical signals to induce 
the heart to self-regenerate the damaged areas. This approach still requires 
further understanding of cardiac signalling pathway and gene expression [23]. 
1.4 Tissue Engineering 
Tissue engineering was defined as a science in its own right when Vacanti and 
Langer published their results in Science in 1993 [24]. Among the several 
definitions, the National Science Foundation defines it as "the application of 
the basis and methods of engineering and life sciences toward tissue 
development of biological substitutes to restore, maintain or improve 
functions" [25]. Regenerative medicine undertakes tissue/organ restoration 
with three main strategies: cell transplantation, bioartificial tissues and 
regeneration in situ [26]. Tissue engineering deals mainly with bioartificial 
tissues although some strategies also contribute with alternative plans to 
regenerate damaged tissue in situ. 
Many research groups are working on tissue regeneration as well as in repair, 
by combining engineering, materials and medical technology looking for a 
guided remodelling of the damaged tissue (Table 1-4). This interdisciplinary 
science started with bone, cartilage and skin, but currently recent projects have 
extended this work to more complex tissues such as liver, nerve, gut, pancreas 
and cardiovascular regeneration. 
Cardiac tissue engineering research groups are looking into novel systems 
which combine different sources of proliferative and differentiated cells as well 
as novel biomaterials. The focus is on the development of alternative grafts. 
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Rapid replacement of the damaged, defective, or lost 
tissue with functional new tissue that resembles, but 
does not replicate the structure, composition, and 
function of the native tissue 
Slow restoration of all components of the repair 
tissue to their original condition such as the new 
tissue is indistinguishable from normal tissue with 
respect to structure, composition and functional 
properties 
Change in tissue structure and composition tn 
response to the local and systemic environmental 
factors that alter the functional tissue properties 
Table 1-4 Tissue healing models 129] 
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These groups also research into suitable environments that encourage rapid 
cell proliferation and full functionality as well as supporting integration to the 
surrounding host tissue [27, 28]. 
1.4.1 Cells for in vitro development of cardiac muscle 
Cells used for tissue engineering purposes should be highly proliferative in the 
early stages for rapid propagation as well as being capable of differentiating to 
become functional. Recently cardiomyocyte precursor cells were fully 
established in vitro, but before that, a number of different cardiac muscle cell 
lines were used to develop in vitro models of tissue engineering constructs 
[29]. Although primary cardiac cells remain the main source for cardiac 
models, availability in large quantities was the main concern for this project. 
The cell line HL-l was used as a model to assess biological properties of this 
novel polymer due to its previous reports as a suitable cardiac model. When 
cultured under certain conditions this cell line, isolated from mouse tissue, 
presents a unique property of spontaneous beating and exhibits typical 
cardiomyocyte morphology. HL-I cells express most of the cardiac specific 
proteins such as atrial natriuretic factor, actin, desmin, tropomyosin, Cx43 and 
myosin heavy chain as well as specific receptors and cardiac electrophysical 
properties. This cell line is now used as a model cell type for cardiac tissue 
engineering and to study the effects of drugs on cardiac tissue [30-32]. 
Cell sources differ when working with in vitro systems for research and when 
developing a graft for clinical applications. Whereas animal cell lines are used 
for laboratory research, the options for clinical implants are extensive. 
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Depending on the source, cells may be autogenic (from the patient), allogenic 
(from the same species) or xenogeneic (from different species). Although the 
first type is the only one not to elicit rejection without the need of 
immunosuppressive therapy, the others can be expanded in vitro and stored in 
advance. 
As mentioned earlier, stem cells have been suggested as an alternative source 
of cardiomyocytes; these cells can be embryonic, foetal, neonatal or adult. 
Availability of foetal and neonatal cells is limited and therefore investigations 
have concentrated with embryonic and adult stem cell sources. Only recently 
three cardiac stem cell lines have been reported, all with different levels of 
cardiac differentiation and protein expression [26]. 
1.4.2 Biomaterials 
Biomaterials are either synthetic or natural materials used for different 
applications but aimed to interact with biological systems. Biomaterials are 
mainly used in medical applications such as implants and surgical aids. 
However they are also used for other purposes such as in vitro cellular studies. 
These materials include metals, ceramics and polymers. It is also common to 
combine two or more of these materials to obtain a new material aiming to 
obtain a composite with better properties than the individual materials [33]. 
Metals 
Metals are inorganic biomaterials which are generally used as alloys due to 
their improved properties. Iron, cobalt, chrome, titanium, aluminium, 
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vanadium, nickel and molybdenum are some of the metallic elements used in 
modern alloys. The use of these materials in the clinic started when surgeons 
realised the ability of the human body to keep metallic materials within the 
body without apparent reaction. Current applications range from dental fillings 
to orthopaedic use [34]. 
The main advantage of metallic biomaterials is their mechanical properties. 
which in general are better for large replacements of hard tissue because of 
their hardness and resistance to wear and tear. However, these materials do 
fatigue and issues of their susceptibility to corrosion limit their use; 
nevertheless these properties can be tailored by adjusting the alloy components 
to obtain more elastic materials, compatible with a wider range of applications. 
Metals impede any biological response because of their inorganic nature but by 
modifying the contact area it is possible to promote a positive reaction from the 
host environment [35]. 
Ceramics 
Ceramics are inorganic materials constituted by metallic and non-metallic 
elements bonded by ionic and covalent bonds. Ceramics are catalogued as 
excellent thermal and electrical isolators as well as possessing resistant to wear 
even under extreme conditions. These properties make ceramics good 
biomaterials for implants. The most common ceramics are alumina 
(Aluminium Oxide), hydroxyapatite and vitro-ceramics (bio-glass), used 
mainly in bone tissue regeneration. Ceramics are brittle materials also used to 
repair joints and teeth. Components in the ceramics determine their properties 
and biological activity; depending on these, ceramics can be classified as inert, 
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bioactive, or resorbable. The first do not interact at all with the host whereas 
the second adhere to the tissue. Resorbable ceramics are those intended to be 
disintegrated and absorbed in the body at the same rate of the new growing 
tissue [36]. 
Polymers 
Polymers are defined as large, complex compounds formed by any kind of 
repeated units joined by covalent bonds in a specific spatial arrangement. 
Polymeric materials can be either inorganic or organic, depending on their 
carbon content. The inorganic polymers include natural (clays and sands) and 
synthetic compounds. Polysaccharides and proteins are natural organic 
polymers, while adhesives, fibres, coatings, plastics and rubbers are synthetic 
organic polymers [37, 38]. Polymers can be long unbranched, branched or 
crosslinked chains of repetitive units, or monomers. This structure determines 
polymer characteristics and therefore the possible applications. Polymers are 
extensively used not only for medical applications but also in different 
manufacturing processes in the pharmaceutical, chemical, food, aerospace and 
automotive industry among others. Table 1.5 summarises the most common 
polymers in regenerative medicine and their use. 
Polymers can also be classified as thermoplastic and thennoset. Thennoplastic 
polymers are mainly linear polymers that can be modified by heat and pressure 
whereas thermoset are usually crosslinked-polymers and cannot be re-shaped 
once they are polymerised. The crystallinity of polymers establishes their 
behaviour in a thennal environment. Pure crystalline polymers behave as 
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Synthetic polymers 
Biodegradable 
Non-Biodegradable 
1\\\11"''> \'>, 
Polyesters (PLLA, PGA, Biomedical applications, 
PGLA, PCL) surgical sutures, scaffolds 
Polyurethanes (PU) 
Silicones 
Polypropylene (PP) 
Polyethylene (PE) 
Poly( ethylene 
(PEG) 
glycol) 
Poly(hydroxyethyl 
methacrylate) (PHEMA) 
Catheters 
Implants, facial devices 
Sutures, heart valves, 
finger joints 
Artificial arteries, contact 
lenses 
Hydrogels, drug delivery 
Lenses, sutures 
Natural polymers (also suitable for hydrogels) 
Proteins 
Polysaccharides 
Collagen, 
fibrinogen, 
polypeptides 
Hyaluronic acid, 
chitosan, 
chondroitin 
gelatine, 
albumin, 
alginate, 
chitin, 
Ligaments, scaffolds, 
wound healing 
Scaffolds, cell 
immobilisation and 
encapsulation, wound 
healing 
Table 1-5 Synthetic and natural polymers with medical applications 137-391 
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glasses below their glass transition temperature (Tg) and as elastomers above 
it. On the other hand, semi-crystalline polymers have limited mechanical 
properties and gas/water permeability. 
Copolymers are a mixture of two polymers, commonly bifunctional units. 
When at least one of the monomer units has two or more binding sites, it can 
bind to two other monomers and cross-links are formed between the different 
polymer chains, obtaining a single networked molecule with different physical 
properties. 
Elastomers are polymers that can be stretched several times and return to its 
original shape without permanent deformation; this characteristic is improved 
when the polymer has been crosslinked. Some elastomers have been used for 
tissue engineering applications due to their flexible physical profile. 
Elastomeric scaffolds are suitable for muscle, cartilage and bone culture since 
it has been shown that tissues maintain better characteristics when cultured 
under physical stimuli such as stress, compression or stretch. 
Optimal monomers for copolymer scaffolds are still to be determined, but 
natural compounds commonly found in the cell may be useful. Organic acids 
have been combined with other synthetic materials to obtain a non-toxic 
copolymer with beneficial effects on tissue culture [39]. Citric acid and 1,8-
octanediol were chosen as the monomeric units of a novel copolymer because 
of their characteristics, as shown in Table 1-6. 
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Molecular Formula 
Molecular Weight 
Melting Point 
Boiling Point 
Solubility in Water 
Autoignition 
Flash Point 
CIII{ I( , \( 11) U;()( 1 \'\11)1(1I 
C6H807 
192.14 
153-154°C 
Decomposes at 175°C 
59.2% 
1011 °C 
100°C 
C8H1802 
149.23 
59-61°C 
Table 1-6 Physical properties of citric acid and 1,8-octanedioI1391 
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1.4.2.a.l Poly-(1,8-octanediol-co-citric acid) 
Poly-(l,8-octanediol-co-citric acid) [POC] is a copolymer suitable for tissue 
engineering applications as recently reported by Yang and colleagues [40]. 
This copolymer is formed by condensation and subsequent crosslinking of two 
monomers: citric acid and 1,8-octanediol. 
Citric acid is a colourless crystalline organic compound that can be found in 
vegetal and animal tissues and fluids and is involved in the Krebs cycle. Citric 
acid is used in the food industry as flavouring, stabilising agent, preservative or 
acidulant. This acid is also used in the pharmaceutical and cosmetic industry 
and in industrial and chemical processing [41]. 
The chemical 1,8-octanediol is a white crystalline powder commonly used as 
an intermediate in polymer synthesis because of its two primary hydroxyl 
groups at terminal locations. This alcohol has other uses in oil refining and in 
pharmaceutical manufacturing [41]. The polymerisation process of citric acid 
and 1,8-octanediol to form the copolymer poly-(1,8-octanediol-co-citric acid) 
is shown in Figure 1-3. 
Composites 
Composites are hybrid compounds formed by two or more natural and/or 
synthetic materials. The blending of different materials allows the targeting of 
particular characteristics of interest for specific applications. These 
combinations offer improved mechanical properties and biocompatibility. 
However not all composites are perfect biomaterials, their mixed composition 
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1,8 octanediol + citric acid 
1400 for 20 minutes 
n 
+ HO 
Figure 1-3 Oligomerisation of citric acid and 1,8-octanediol 
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can make them liable to fractures and cracks, damaging the structure and 
risking the failure of the construct. Composites have been used in tissue 
engineering to promote cellular activity and adhesion. It is common to combine 
a natural protein, such as collagen, to assure the biological response with a 
synthetic material such as metals or polymers to improve the mechanical 
properties of the structure [36]. 
1.4.3 Scaffolds for Tissue Engineering 
Scaffolds are structures used in tissue engineering either to provide physical 
support or to introduce living cells in damaged areas within an organ or tissue. 
In the first case, the scaffold fills the voids caused by lesions, encouraging 
rapid population of host cells. In the second case, the scaffold sustains the 
survival of the new implanted cells providing not only a template of physical 
matrix for the cells to attach to, but also in some circumstances biochemical 
factors; this assures their survival and promotes biological responses to 
encourage the regenerative process within the host. In order to be suitable for 
tissue engineering applications, scaffolds must meet certain characteristics such 
as biodegradability, biocompatibility and micro and macrostructure suitable for 
the cell type and tissue (Table 1-7) [42-44]. 
Biodegradability levels vary on the specific application of the biomaterial. In 
certain applications a biomaterial may be required to remain for years without 
any degradation to substitute tissue loss. However another tissue engineering 
approach is to provide a temporal support by filling the void and then promote 
the healing so that the new repaired tissue will be entirely from the host and 
43 
Non-toxic material 
Surface modified to enhance cell attachment 
Elicit minor or non-immunological/inflammatory 
response 
Degradation ratio should match removal and tissue 
regeneration ratio 
Optimum pore size, porosity and interconnectivity 
Must provide a three-dimensional template and 
ideally should present organised pores to orientate 
cell attachment 
Must match the mechanical properties of the native 
tissue 
Table 1-7 Description of the key characteristics in scaffolds de ign r40-4 t I 
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any residue of the biomaterial will be absorbed and disposed of [45]. 
Considering this, it is important to control the degradation rate of the material 
depending on the rate of tissue repair, but also on the rate of degradation 
product removal in order to decrease undesired host responses. If the 
degradation is too rapid, this could overwhelm the system and cause graft 
rejection or failure due to a massive immune response. Degradation products 
of synthetic materials can be a problem as local pH decreases and prompts a 
biological reaction [46]. Bio-absorbable materials assure that secondary 
residues will be discarded through cellular metabolic pathways. Knowing the 
cellular mechanisms and repair time of the target area defines the biomaterial 
that can be used. Currently it is possible to vary degradation rates for most of 
the biomaterials by altering their structure via physical or chemical 
modifications, such as crosslinking [47]. Biocompatibility concerns the 
biological response that the biomaterial could trigger in the host. It is important 
to keep the immunological response to a minimum level so no significant or 
prolonged reaction is caused and therefore the risk of rejection is reduced. This 
is a major issue as immunological rejection is one of the main causes of 
transplantation failure. Biocompatibility can be modified by introducing cells 
with minor or non antigen recognition such as stem cells or the own patient's 
cells. Rapid degradation rates can also affect bio-compatibility as discussed 
earlier. It is vital to use a material that will promote cellular attachment and 
proliferation in the construct speeding up the remodelling of the area. As 
synthetic materials do not express natural recognition molecules, tissue 
engineers frequently use either a combination of natural and synthetic 
45 
materials. Another strategy is to chemically modify surfaces to improve cell 
attachment, proliferation and differentiation to the biomaterial [48]. 
The structure of a scaffold is defined by the porosity, pore Size, 
interconnectivity of the pores, mechanical properties and the feasibility of 
processing large amounts in specific shapes and dimensions. Porosity 
represents the percentage of void spaces within the scaffold. Levels of 60% -
99% porous allow the cells to rapidly populate throughout the scaffold. Pore 
size is important as pores <100 microns could block the movement or 
differentiation of cells, whereas pores> 300-500 microns could isolate cells 
within confined areas and reduce the population expansion pace [49]. 
Interconnectivity allows the cells to move around the scaffold and to 
communicate between them by chemical Imechanical lelectrical ways. Open 
porous interconnected structures will facilitate vascularisation and nutrients 
transport ensuring that not only peripheral cells will survive but also that 
central cells will be provided with oxygen and nutrients. With cardiomyocytes 
highly susceptible to ischemia, a porous scaffold could provide increased levels 
of oxygen and nutrients. as well as different degradation profile and 
mechanical properties to those of cell sheets. Mechanical properties of 
biomaterials allow the scaffold to support tissue growth. Hard, inelastic 
scaffolds are used in applications such as bone regeneration, whereas materials 
with flexible properties are required for soft tissues such as cartilage and 
cardiovascular grafts. Tissue engineers have tried to match the mechanical 
properties of the target tissue to provide a closer match of the artificial graft. 
Properties such as elasticity, maximum elongation without deformation, force 
to break and stability are important to characterise a scaffold. It is also 
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important that the scaffold can be produced in a shape and dimensions that will 
suit the target tissue. All these characteristics are related and in most of the 
cases if one is modified at least one other factor will be as well [43]. Currently 
the most common scaffolds used in tissue engineering are natural polymers 
such as collagen, alginate and glycosaminoglycan; synthetic polymers such as 
PLA and PLGA and hydroxyapatite and calcium phosphates ceramics [44]. 
Scaffold Fabrication 
Biomaterials can be processed through different methods to obtain porous 
structures. Although they offer several advantages, few of these methods are 
able to control internal structure and homogeneity. New tactics provide a better 
control of macro and microstructure; yet most of the cases are limited to certain 
types of biomaterials. The most common approaches to process biomaterials 
into porous scaffolds are summarised in Table 1-8. 
1.4.3.a.l Solvent Casting and Particulate Leaching (SCPL) 
This method allows the processing of solid biomaterials, soluble in a range of 
organic solvents, through the incorporation of porogen particles throughout the 
polymer. Solvent and then porogen are removed to leave a porous structure in 
the shape of a mould. Porogens used in SCPL include inorganic salts such as 
NaCl and organic crystals such as glucose. The benefits of this technique 
include a controlled pore size and porosity and are controlled by the quantity 
and size of the porogen. Unfortunately structures processed by SCPL cannot be 
thicker than a couple of millimetres due to the inability to control large 
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Solvent Casting & Particulate Leaching (SCPL) 
Phase Separation 
Fibre bonding 
Rapid prototyping (Computer Assisted 
DesignIManufacture) 
Gas Foaming (High Pressure scC02) 
Electro spinning 
High and controlled porosity, crystallinity, pore size, 
shape and dimensions can be tailored, independent 
control of porosity and pore size 
Highly porous and interconnected structures, non-
compromised activity of biological molecules 
High porosity 
Three-dimensional matrix, control of 
macrostructure, independent control of pore size and 
porosity 
No organic solvents involved 
High porosity, high sUrface-area-to-volume ratio 
Table 1-8 Standard techniques for biomaterial processing into porous scaffolds (33, 41, 50-571 
Limited thickness up to 3 mm, solvent and porogen residues, 
limited interconnectivity, poor control of internal structure 
Limited to small pore sizes, solvent residues 
Limited range of polymers, mechanical properties mostly 
suitable for soft tissue applications 
Solvent residues, mechanical properties suitable mostly for 
soft tissue applications, limited interconnectivity 
Mostly non porous external surface, low interconnectivity, 
limited to polymers soluble in supercritical gases 
Limited to soluble polymers with certain viscosity and 
conductivity, wide distribution of pore diameter 
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structures homogeneously, In addition to the difficulty of manipUlating the 
interconnectivity of the pores or their orientation. The major drawback is that 
the organic solvent cannot be completely removed and residues could result in 
cellular toxicity [50-51]. 
1.4.3.a.2 Phase Separation 
Phase separation is a thermally induced separation of an emulsion formed by a 
material dissolved in an organic solvent and water. This emulsion is cast in a 
mould and rapidly frozen and then freeze-dried, or cooled down and vacuum 
dried so the water and solvent are removed from the emulsion leaving a porous 
structure. Although these methods are less time consuming than SCPL, 
porosity nor pore size cannot be controlled and still requires the use of an 
organic solvent [33]. 
1.4.3.a.3 Fibre Bonding 
This method uses individual polymer fibres to prepare either knitted or woven 
3D structures. Although it generates scaffolds with high porosity values, 
disadvantages include the difficulty of producing a controlled pore size and the 
use of solvents and high temperatures. It is difficult to incorporate bioactive 
molecules and to produce large amounts in a short period of time [52-53]. 
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1.4.3.a.4 Rapid prototyping 
This method, also known as solid free-form fabrication (SFF), is based on 
structuring layers of biomaterial to engineer a 3D scaffold aided by computer-
controlled systems. This technique, used first to model biological structures, 
provides scaffolds with a defined porosity, interconnectivity, pore size, 
microstructure and mechanical properties. Current strategies include fuse 
deposition modelling, stereo lithography (SLA), selective laser sintering, 
ballistic particle manufacturing and 3D printing [33]. 
1.4.3.a.5 Gas foaming (super critical C02) 
Carbon Dioxide (C02) is a non-flammable and virtually inert compound that 
changes into a supercritical phase when it is pressurised and heated to its 
critical pressure and temperature (1,070 psi and 31 QC). In this phase its 
physical properties are both those of liquid and gas phases, including a lower 
surface tension than liquids (allowing spreading out along a surface) and the 
ability to act as a powerful solvent. Once the scC02 is dissolved in a material, 
the release of pressure at a high rate entraps the C02 in the material forming 
bubbles and makes the compound foam when the C02 returns to the gaseous 
phase. This technology is non-toxic, friendly to biological systems, recyclable, 
and easily scalable [41, 54-56]. 
scC02 technology has been suggested as an effective method to engmeer 
solvent-free biomaterials, such as polymers, which can be foamed to obtain 
porous scaffolds for biomedical applications [55]. Barry et al demonstrated 
that non-degradable polymer systems can be foamed into highly porous 
scaffolds with a large percentage of open pores using the scC02 process, and 
that this modification in the structure supports cell culture in vitro [57]. 
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1.4.3.a.6 Electrospining 
This method produces interconnected webs of microfibres, from microns to 
nanometres, of natural or synthetic polymers creating a high porous scaffold 
with high surface-area-to-volume ratio and a wide distribution in the pore size. 
The principle of this technique is to pass a polymer solution through a high-
voltage electrostatic field so the solution is ejected due to the surface tension 
forces. The solvent evaporates and the polymer is left into stretched fibres. The 
characteristics of these electro-spun scaffolds are defined by the operational 
parameters of the technique: flow rate, distance between the tip and the 
collector and applied electric potential. 
Although this method produces scaffolds similar to ECM structures, the 
polymer solutions suitable for this approach are limited by fluid properties such 
as conductivity, viscosity, dielectric constant, surface tension and boiling point 
[33]. 
State of the art of scaffolds for cardiac muscle 
An initial challenge of generating an engineered cardiac patch is the 
development of the ideal biomaterial for cardiomyocyte culture. Researchers 
have proposed both synthetic and natural materials to generate a suitable 
cardiac graft. Bursac et al. assessed a 3D spinner flask culture of primary rat 
heart cells seeded into poly-(glycolic acid) (PGA) fibres. Their results showed 
that they were able to generate a functional construct within the first 3 days, 
including normal protein expression of cardiac and muscle markers such as 
tropomyosin and actin, cell-to-cell connections and spontaneous contractions 
but this activity decreased in the following 4 days (day 4-7) [58]. 
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Studies not only involving the physical properties of a biomaterial but also its 
biochemistry have generated useful information. Novel approaches to form a 
3D construct have been suggested. Shimizu et al used a temperature-responsive 
polymer to pre-coat culture dishes. Cardiomyocytes were seeded into these 
plates and once a monolayer was formed, the temperature was decreased to 20° 
C to detach the cells and the monolayer was placed on top of another 
cardiomyocyte monolayer and cultured further. Both layers integrated and 
resulted in a functional culture with cell-to-cell connections between them [59]. 
McDevitt et al cultured cardiomyocytes on a biodegradable, elastomeric 
polyurethane film. This material, used as a scaffold, allowed the development 
of spatially organised layers of cardiomyocytes in vitro. Biodegradable 
elastomeric polymeric materials as well as hydrogels are suitable because of 
their mechanical properties that meet the force-generating demands of the 
contractile tissue. These segmented polyurethane elastomers were synthesised 
with the use of a lysine-based diisocyanate, polycaprolactone and a 
phenylalanine chain extender. The morphology, stability and differentiation of 
the culture was similar to those cultured on non-elastomeric polystyrene or 
glass [23]. The use of elastomers to process porous scaffolds has been limited 
due to their lack of biodegradability. 
Natural polymers have been used for cardiovascular engineering. Sodian et at 
reported that poly-(hydroxyalkanoate) (PHA) is a useful material for 
cardiovascular engineering. This bacterial-derived polymer is thermoplastic 
and can be moulded into almost any shape. For example, in cardiac valve 
engineering, this polymer showed high elasticity and mechanical strength 
appropriate for this application [60]. 
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Polonchuk et al tried a novel approach for cardiomyocyte culture. Titanium 
dioxide ceramics were used as this material mimics cell surface topography 
and promotes vinculin expression, a protein that defines cell shape. This 
molecular stabilisation maintained the cardiomyocyte differentiated phenotype 
for nine days [61]. 
Another innovative method is the one published by Shin et al. They fabricated 
a nanofibrous mesh of polycaprolactone by electrospinning and seeded it with 
neonatal rat cardiomyocytes. After culturing these under static conditions, 
contractile constructs were obtained with more accurate cardiac protein 
expression and good cellular attachment [62]. 
Schmidt et al believe that synthetic materials should not be used as scaffolds 
because of the residual cellular components and undesired effects such as 
calcification and immunological recognition. Natural sources are suitable for 
cardiovascular remodelling but cross-linking is needed for mechanical 
compliance [63]. An example is the work reported by Qing Ye et al using 
fibrin gels. They found that these were suitable for 3D engineered structures 
because of the lack of toxic degradation or inflammatory responses that is seen 
with synthetic materials [64]. 
Collagen scaffolds are commonly used for tissue engineering. Kim et at 
demonstrated its elastic properties during cyclic strain. They also assessed 
elastin content on smooth muscle cell culture and found higher levels than 
those cultured in PGA. Elastin is important due to its role in the regulation of 
proliferation and organisation of cells [65]. Costa et al reported that the culture 
of cardiomyocytes in collagen showed normal mechanical and electrical 
behaviour. They exposed the collagen system to tension by clamping two 
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ends of the gel to a stretch device to assess the effect on the alignment of the 
cells. The results confirmed that the gel orientation is parallel to free 
boundaries rather than to lines of tension, and independent to the geometry of 
the construct [66]. However other results have shown that collagen exhibited 
limited mechanical properties and batch-to-batch variation [67] and Radisic 
and Vunjak-Novakovic stated that collagen is not a candidate for cardiac 
scaffolds because of its "poor structural integrity" [68]. 
Three-dimensional scaffolds have been produced as well as 2D. Evans et al 
have worked on the development of a novel model to obtain a better 
understanding of cardiomyocyte differentiation. The system is a 3D tubular 
scaffold made from aligned type I collagen strands that appeared to induce a 
switch in the cellular growth from a hyperplastic to a quiescent phenotype. 
The authors also concluded that the system promoted myofibrillogenesis as 
well as cell-to-cell connections. Moreover the constructs showed an aligned 
phenotype along the tube [69]. 
Collagen-based scaffolds have been combined with other materials. Radisic et 
al worked on the hypothesis that a rapid gel-seeding with media perfusion 
would improve the rate, yield, viability and uniformity of cell seeding. 
Neonatal rat cardiomyocytes and the c2c12 cell line were seeded in collagen 
sponges, with Matrigel as the vehicle, in either perfusion cartridges or in 
orbitally mixed Petri dishes. Results showed that cell viability was higher in 
perfusion cartridges than in mixed dishes. Perfusion conditions encouraged 
spatial cell distribution as well as proliferation and differentiation, confirmed 
by synchronous contractions of constructs under electrical stimulation [70]. 
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Kofidis et af built a bioartificial myocardial tissue by seeding neonatal rat 
cardiomyocytes in a novel scaffold, a bovine collagen type I-based matrix that 
has been used as a hemosypticum (patches used to stop bleeding) in surgery. 
This "tissue fleece" patch has a similar elasticity curve to that of the 
myocardium and supported contractile grafts with normal cardiac protein 
expression for 12 weeks [71]. 
Alginate has also been used in several studies. Dar et af used porous alginate 
scaffolds to seed cardiomyocytes and obtain 3D high cell density constructs 
with a uniform distribution. The centrifugal force applied during the seeding 
allowed a uniform cell distribution throughout the alginate scaffold. Although 
the seeded cellular density was high the cardiomyocytes did not differentiate in 
this system [72]. 
Surface modifications are also used to improve the rate of cell binding to the 
biomaterial. Hubbell et af have conjugated growth factors and peptide 
sequences namely RGD from fibronectin and YIGSR from laminin on a 
collagen matrix via a polyethyleneglycol (PEG) spacer. This technique allowed 
a better attachment of cells to the surface [73]. Zisch et al worked with a 
vascular endothelial growth factor (VEGF)-modified fibrin injectable matrix 
that gels under physiological conditions in a single-step reaction. It has been 
proposed that this matrix could be used for multiple clinical applications such 
as an angiogenic response inducer in ischemic regions or implants [74]. These 
works are summarised in table 1.9. 
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Cardiomyocytes in both spinner flasks and rotating vessels. 
Results showed that cardiomyocytes cultured on PGA disks 
(non-coated or coated with laminin) in a rotating bioreactor 
possessed enhanced viability, electrical coupling and 
differentiation because of the laminar flow conditions of the 
rotating vessel compared to the turbulent environment of the 
ner flask. 
Cardiac constructs, cultured whilst being stretched, exhibited an 
increased amount of collagen in the matrix compared to those 
cultured statically. 
Constructs cultured at an oxygen pressure of 160 mm Hg 
expressed higher protein and deoxyribonucleic acid (DNA) 
levels than those cultured at 60 mm Hg. 
The stroke volume, rate and the inspiration/expiration time of 
the ventilator of the perfusion system was adjusted to achieve a 
biomechanical stimulus in the perfusion system through 
different pulsatile flows and pressures. 
A perfused system provided homogenous conditions showing a 
uniform cell distribution across the entire construct. 
A minimal cell seeding density of 4-8 x 106 cells/disk was 
required to preserve the construct structural density over a two 
week culture period. Rotating culture increased the quality of 
the constructs possibly due to the higher supply of oxygen. 
A stirred bioreactor provided mechanical stimulation via a 
media pulsatile system which induced increased levels of 
collagen deposition in the constructs 
Mechanical stress is a key factor for the development of 
haemodynamic overload-induced cardiac hypertrophy and 
therefore in the developing cardiac constructs. 
The effect on myofibril orientation was assessed by changing 
the duration of the stretching to 120% in length at 30 
cycles/min. The stimulus induced a parallel orientation of fibrils 
to the force when the culture was stretched in early stages of 
development meanwhile stretching in the later stages induced a 
perpendicular orientation of the myofibrils 
Table 1-9 State of the art in stimulated cardiac systems \75-84\ 
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1.4.4 Bioreactors 
A bioreactor is a system that provides a controlled environment for cell growth 
(Figure 1-4). A bioreactor was first used for large scale fermentation processes 
including fermented beverages and antibiotics. Recently bioreactors have 
evolved into specialised specific systems for high technology applications such 
as recombinant proteins and tissue engineering. Because of the wide range of 
applications, bioreactors vary from simple agitated tanks to complex 
electronically operated devices. 
Nutrient availability is the major concern for 3D culture as mass transport 
between constructs and media is carried out by convection, whereas within the 
constructs is only by diffusion. Tissue engineering dynamic bioreactors aims to 
improve this mass transfer by laminar shear to assure that all the cells within 
the constructs receive the same levels of nutrients, gases and in some cases to 
assure the removal of waste or secondary metabolites [33]. 
In addition to the mass transfer, bioreactors allow the tissue engineers to mimic 
the environment of the host tissue stimulating the constructs by electrical or 
mechanical forces. Mechanical stimulation during cell culture has been shown 
as an effective method to promote cell growth, rapid differentiation and protein 
expression compared to static culture. This mechanical stimulus can be either 
via flow-mediated shear stress, uniaxiallbiaxial strain or hydrostatic pressures. 
There are three main types of general bioreactors: batch, fed-batch and 
continuous. Batch bioreactors, such as spinner flasks or rotary cell bioreactors, 
are sealed vessels where the constructs are cultured with media circulating at a 
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Figure 1-4 Principle of a bioreactor 
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and shear stress) 
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controlled speed for a determined time. Fed-batch is the same principle with 
the exception that nutrients are added when needed, so the final volume of 
media is greater than the initial. Continuous bioreactors, such as perfusion or 
pulsatile, have a constant flow of media that improves the nutrient exchange 
and cell growth and helps carry out the waste. Media is never depleted and the 
steady flow provides an additional stimulus to the cells. Spinner flasks and 
rotary cell bioreactors can also be modified to operate as a continuous system 
although that depends on the cell type and its requirements [29]. 
Tissue engineered bioreactors are mostly small custom-designs as each 
application requires not only different operational parameters and conformation 
for the specific construct. An advantage is that contamination risks are 
generally reduced as handling of constructs decreases in closed systems and the 
sterility is preserved for a longer time; however this depends on each system as 
some specialised bioreactors may need continuous supervision. 
Current research in culture environments for cardiomyocyte culture 
Further challenges for the system are the in-vitro culture conditions such as 
mechanical or electrical stimuli that could be applied to it. Studies using 
various biomaterials and culture systems have demonstrated different effects 
on cardiac cells. Papadaki et al. compared the effect and quality of 
cardiomyocyte culture, in both spinner flasks and rotating vessels, on PGA 
disks that were non-coated or coated with laminin. Following a period of time 
in culture, the constructs were assessed for protein expression connexin43 
(Cx43), myosin heavy chain (MHC) and creatine kinase MM (CK-MM) as 
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well as electrophysical properties under stimulation. They showed that 
cardiomyocytes cultured in a rotating bioreactor possessed enhanced viability, 
electrical coupling and differentiation because of the laminar flow conditions 
of the rotating vessel compared to the turbulent environment of the spinner 
flask [75]. Different mechanical-stimulated culture systems have been shown 
to influence the proliferation, protein expression and morphology of the 
cultured cells and to impact directly on the resultant structure and properties of 
cardiac constructs. Also, Akhyari et al. concluded that a mechanical regimen 
could improve the formation of 3D tissue engineered cardiac graft by 
promoting the proliferation and distribution of cardiac cells and by stimulating 
organised matrix formation. They showed that cardiac constructs cultured 
whilst being stretched exhibited an increased amount of collagen in the matrix 
compared to those cultured statically [75]. 
A direct perfusion culture system has been used to culture PGA scaffolds 
seeded with cardiomyocytes. Different concentrations of oxygen were used in 
the system to investigate the effects on the resulting constructs. Constructs 
cultured at an oxygen pressure of 160 mm Hg expressed higher protein and 
deoxyribonucleic acid (DNA) levels than those cultured at 60 mm Hg. This 
work also demonstrated that serially connected constructs enhance spatial 
uniformity by eliminating diffusional transport over large distances [77]. 
Sodian et al also worked with perfusion systems for cardiomyocyte culture. 
They adjusted the stroke volume, the stroke rate and the inspiration/expiration 
time of the ventilator to achieve a biomechanical stimulus in the perfusion 
system through different pulsatile flows and pressures [78]. 
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Carrier et af have been working with cardiomyocyte cultures in a perfused 
environment. This system provided homogenous conditions showing a uniform 
cell distribution across the entire construct. However, the cardiomyocytes 
exhibited a rounded phenotype which may have been the result of shear stress 
from the media flow [79]. The same group conducted experiments with PGA 
disk-shaped, non woven meshes (5 mm diameter x 2 mm thick) seeded with 
either rat or chick embryo ventricular cardiomyocytes at different cell 
concentrations. They cultured the seeded dishes using different parameters 
including static culture, dynamic culture in a spinner flask (60, 90 rpm) and 
two rotating micro gravity simulating bioreactors: high aspect ratio vessel 
(HARV) and slow turning lateral vessel (STLV). Their results showed that a 
minimal cell seeding density of 4-8 x 106 cells/disk was required to preserve 
the construct structural density over a two week culture period. Rotating 
culture increased the quality of the constructs possibly due to the higher supply 
of oxygen. A morphological improvement was observed as the rotated 
constructs showed a more uniform distribution of cells throughout the scaffold 
[80]. 
Other mechanical changes such as pulsatile stimuli have been investigated. 
Solan et al worked with a tubular PGA scaffold in a stirred bioreactor that 
provided mechanical stimulation via a media pulsatile system which induced 
increased levels of collagen deposition in the constructs [81]. 
Another approach to improve cardiac muscle regeneration is to subject the 
construct to physical activity (stress or strain) during culture. Sugden et al 
reported the main differences between stress and strain in cardiac tissue. They 
also discussed mechanotransduction conditions of the heart pump [82]. Ruwhof 
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et al described how the effect of mechanical stress is a key factor for the 
development of haemodynamic overload-induced cardiac hypertrophy and 
therefore in the developing cardiac constructs. This team used the Flexercell 
Strain culture system to culture monolayer cardiomyocytes under cyclic stretch 
conditions to analyze growth factor and hormone release as a response to the 
mechanical force. Cardiomyocytes secreted high levels of Transforming 
Growth Factor beta ( T G F ~ ) ) and Atrial Natriuretic Factor (ANF) when 
subjected to this kind of forces [83]. 
Silicone dishes used to cyclically stretch cardiomyocytes cultures were used by 
Kada et al. They assessed the effect on myofibril orientation by changing the 
duration of the stretching to 120% in length at 30 cycles/min. The stimulus 
induced a parallel orientation of fibrils to the force when the culture was 
stretched in early stages of development meanwhile stretching in the later 
stages induced a perpendicular orientation of the myofibrils [84]. 
Several strategies have been developed to generate a clinically viable cardiac 
graft but there are still some unresolved issues. Reffelman et al reported that 
long-term in vitro culture of cardiomyocyte grafts results in the cells 
dedifferentiating and developing hypertrophic growth patterns. Mechanical and 
electrical integration is not completed because the graft is commonly 
surrounded by collagen and scar tissue. Cardiomyocyte grafts have benefits on 
the cardiac tissue but the muscle can not be remodelled [85]. In order to 
overcome these problems it will be needed to optimise the cell source and 
differentiation stage and the in vitro culture time. 
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1.5 Aims of the Study 
The first aim of this work was to generate a flexible scaffold using poe to 
mimic the elements in cardiac tissue. This work looked into the physical and 
mechanical properties of this poe scaffold as well as cellular compatibility in 
2D and 3D systems. The effect of mechanical forces applied during in vitro 
culture was then assessed to determine if they assisted in the maintenance of a 
cardiomyocyte cell line and tissue formation. 
This polyester, previously described by Yang et al [33], is a novel elastomeric 
biomaterial that can be processed into porous scaffolds with optimum pore size 
of pore and porosity for cardiomyocyte infiltration and growth. Physical 
characterisation of this flexible scaffold as well as modifications to improve 
cell viability and attachment were assessed. A stretching bioreactor was used 
to mimic the cardiac mechanical stimuli to determine whether this could have 
any beneficial impact on the development of the cardiac construct. 
1.5.1 Objectives 
The specific objectives of this work were: 
1. Synthesise a novel flexible biomaterial (POC) and process it 
into porous scaffolds suitable for cardiac muscle tissue 
engineering. 
2. Characterise these POC scaffolds with respect to mechanical 
properties, degradation and structure. 
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3. Assess cardiomyocyte cell adhesion to the POC and evaluate the 
modification of the material surface with ECM proteins to 
improve cell adhesion. 
4. Assess different seeding methods to establish an efficient 
method to seed cells into POC scaffolds. 
5. Compare cell survival, morphology and gene expressIOn of 
constructs of cardiomyocytes seeded into POC scaffolds 
cultured in a controlled environment under the effect of 
mechanical stimuli to those cultured without it. 
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2 General Materials and Methods 
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2.1 Polymer Preparation, Processing and Characterisation 
2.1.1 Polymer synthesis 
Equimolar quantities of 1,8-octanediol (Sigma, UK) and citric acid (Sigma, 
UK) were added to a round-bottomed flask. The mixture was melted by 
stirring at 1600 e in a paraffin bath after which the temperature was lowered to 
140oe. The stirring conditions and temperature were held for a further 20 
minutes [41]. The pre-polymer solution was allowed to cool to room 
temperature (RT) and then dissolved in acetone (Sigma, UK) at 33.3% (w/v) 
solution and stirred for 48 h to decrease the viscosity. The pre-polymer 
solution was poured into a poly-(tetrafluoroethylene) [TEFLON] mould to 
obtain either discs (10 mm diameter) or rectangular scaffolds (56 mm x 24 mm 
x 2.5 mm) and the solvent was allowed to evaporate overnight. Moulds were 
transfer to an oven and cross-linked at 800 e and atmospheric pressure for two 
weeks to obtain poe films. 
2.1.2 Scaffold manufacture 
Gas foaming processing (scC02) 
Foaming was attempted as follows: the copolymer was placed into the sce02 
pressure system (Figure 2-1) and then the autoclave was clamped and 
tightened. The temperature was measured and controlled using a temperature 
controller and monitor, while the pressure was controlled by a back pressure 
regulator (BPR) and a computer software program (Flowplot V3.04). The 
program used for these experiments involved filling the chamber with food 
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Figure 2-1 Digital image of the supercritical Carbon Dioxide (scC02) system 
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grade C02 (Cryoservice, UK) up to 207 bar for 20 min, the system was held 
at 207 bar (soak time) and then vented over I hour. Soaking time ranged from 
1 to 12 hours. Once the system was at atmospheric conditions, the chamber 
was opened and the foamed scaffold was removed. 
A similar autoclave but with a sapphire view cell was used to monitor the 
foaming process using a Rigid Borescope (Olympus Ind., UK) and a Digital 
Video Camcorder MV 450 (Canon, UK). Photographs of the scaffolds were 
taken using a Digital Camera A60 (Canon, UK) 
Solvent cast 
POC was processed by this method to obtain porous structures. Briefly the 
POC pre-polymer/acetone solution was poured into a Teflon mould (disc or 
rectangular shape, as in 2.1.1) containing sieved sodium chloride of particle 
size greater than 212 microns (Sigma, UK) and covered to allow the salt to 
soak for 30 minutes. The acetone was allowed to evaporate off for 24 hours at 
room temperature after which the samples were transferred to an oven for the 
crosslinking stage for two weeks at 80°C. The scaffolds were cast out and 
washed several times in distilled water for three days to remove all the salt 
particles. The monomer residues were then washed out in PBS to adjust the 
pH to physiological levels. The material was either oven dried at 80·C for 2 
hours and stored at room temperature or stored at -20T and freeze-dried 
overnight before use. The porosity was tailored by an increment or decrement 
of the salt content to obtain a final theoretical porosity of 60%, 70% or 80%. 
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2.1.3 Polymer Characterisation 
SEM 
The pore morphologies of the foamed samples were investigated using a JEOL 
JSM 6060 microscope. The samples were analysed in triplicate, briefly 
scaffolds were sputter coated with gold at an Argon pressure of 13 Pa for 3 
minutes at a current rate of 14 mA. Samples were imaged at an accelerating 
voltage of 10 and at a spot size of 40. 
Random areas were selected to evaluate pore size. The pore diameter was 
determined by measuring the distance across the pores using JEOL software. A 
minimum sample size of 50 pores in each of 5 scaffolds was counted. Pore size 
distribution was determined as well as mean pore diameter. 
Microtomography (microCT) 
A micro-CT system (J,1CT 40, Scanco Medical, Bassersdorf, Switzerland) was 
used to non-destructively image and visualise the three dimensional micro-
morphology as previously described (Figure 2-2) [44]. Scaffolds were mounted 
on a stage within the imaging system and subsequently scanned at a voltage of 
55 kV and a current of 143 mA. Specimens were scanned at a 30J,1m resolution 
with an integration time of 300 ms to produce 3D images. Raw 20 images 
were thresholded to remove background values (threshold value = 70). From 
this analysis porosity and pore size was calculated using the Scanco software. 
69 
Figure 2-2 Schematic diagram of a cone beam X-ray microtomography system [86] 
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Helium picnometry 
A Micromeritics AccuPyc 1330 Pycnometer (Figure 6-3) was used to evaluate 
the density of the scaffolds (p) testing three different scaffolds for each 
porosity. Gross measurements and weight were used to calculate the geometric 
density pgeometric. pgeometric = m/v, where m is the mass and v is the 
volume of the porous POC scaffold. The volume of the discs was calculated 
using the equation v=m2h where r is the radius of the disc and h is the height. 
The mean disc height and diameter were measured using standard engineering 
callipers (Mitutoyo UK Ltd.). The total and the closed porosities of the 
material were calculated using Equations 2.1 and 2.2. These formulae relate 
the porosity (P) to the densities (p) of the foamed material. 
P closed = (l-(Ppycnometry tPbulk) x 100 
P total = (l-(Pgeometric tPbult) X 100 
Mechanical properties 
Equation 2.1 
Equation 2.2 
Tensile tests were conducted in triplicate on a TA.xTplus Texture Analyser 
(Stable Micro Systems ®) with a load cell of 5 kg, using pneumatic clamps to 
secure the samples. A minimum of three scaffolds (8 mm x 54 mm x 2.5 mm, 
length x width x thickness) were tested at four different rates: 18 mm/min, 180 
mm/min, 300 mmlmin and 500 mm/min. Strain, stress, maximum elongation 
and the engineering Young's modulus values were obtained using the package 
Texture Exponent 32® (Stable Micro Systems). The same texture analyser was 
used to evaluate in triplicate the fatigue of the porous material over 1000 
cycles at 300mmlmin, 60% strain and at a frequency of 0.27 Hz. 
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Degradation 
In-vitro degradation was evaluated by weighing dry POC scaffold samples (8 
mm x 54 mm x 2.5 mm, length x width x thickness), placing them in a 
container with 20 ml of PBS and incubating them at 37°C for up to 6 months. 
Specimens were washed as required to maintain a pH of7.5. After incubation, 
samples were oven-dried and weighed to assess the loss of dry-weight. [87-88] 
2.2 Cell culture methods 
2.2.1 Culture ofHL-l cardiomyocytes 
The mouse cardiac myocyte cell line HL-l was a kind gift from Dr. Claycomb 
(Louisiana State University - Health Sciences Center, USA) and was grown at 
37°C in a humidified atmosphere 5% C02 in air in medium: Claycomb 
Medium (JRH Biosciences) supplemented with 10% (v/v) foetal bovine serum 
(JRH Biosciences, USA), 0.1 mM norepinephrine (Sigma, Poole, UK), 2 mM 
glutamine (Sigma, Poole, UK) and 100 U/ml: 100 ~ g / m l l
Penicillin/Streptomycin (Sigma, Poole UK). HL-I cells were seeded into 
gelatine (DIFCO, UK)/fibronectin (Sigma, Poole, UK) pre-coated 25 and 75 
cm
2 
cell culture flasks as described by the supplier [30]. The medium was 
changed every 24 h. Serial passages were made by trypsination, centrifugation 
and re-suspension of pellets of sub-confluent mono layers and then re-plated at 
a dilution of 1 :3. 
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2.2.2 Culture of c2c12 myocytes 
The mouse myoblast cell line c2c 12 were obtained from the ECCAC and 
cultured in 25 and 75 cm2 cell culture flasks at 3rc in a humidified 
atmosphere 5% C02 in air in medium: DMEM media (Gibco, UK) 
supplemented with 10% (v/v) foetal bovine serum, 2 mM glutamine (Sigma, 
Poole, UK) and 100 V/ml penicillin, 100 flg/ml streptomycin and 0.25 flg/ml 
amphotericin B (Sigma, Poole UK). C2cl2 cells were plated into T-25 and T-
75 cell culture flasks as described by the supplier. The medium was changed 
every 48 h. Serial passages were made by trypsination, centrifugation and re-
suspension of pellets of sub-confluent monolayers and then re-plated at a 
dilution of 1 :6 or 1: 1 O. 
2.3 Culture of cell seeded scaffolds 
2.3.1 Preparation of POC films and scaffolds 
Non porous POC films were cut into squares (0.70 cm2) whereas POC 
scaffolds were cut in small rectangular pieces of 1 x 3 cm. POC structures 
were sterilised by incubation In a solution of 10% (v/v) 
antibiotics/antimycotics (100 U/ml penicillin, 100 flglml streptomycin and 0.25 
flglml amphotericin B) for 1 hour, washed with sterile PBS, then incubated in 
70% (v/v) ethanol for 30 min, washed again and finally by ultraviolet (UV) 
light exposure for 15 minutes each side. Sterile POC films and materials were 
stored at RT until use. Prior to seeding POC structures were washed in PBS to 
remove acidic residues, incubated in non-supplemented DMEM at 4°C for 24 
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hours, washed again in sterile PBS and modified with an ECM protein as 
required (Section 2.3.2). 
2.3.2 Modification of POC surface with ECM proteins 
Collagen, laminin and fibronectin were chosen to modify the nature of the 
polymer as they constitute the majority of the cardiac ECM. Due to the high 
temperatures used to synthesise the elastomer, these proteins could not be 
incorporated into the material. Hence POC surface was modified by passive 
adsorption even though there was a risk of protein detachment. For adhesion 
studies, POC films were incubated in a fibronectin (Sigma, Poole UK) at 400 
J..lg/cm2,40 J..lg/cm2 and 4 J..lg/cm2, collagen (Sigma, Poole UK) at 10 J..lg/cm2, 1 
J..lg/cm2 and 0.1 J..lg/cm2 or laminin (Sigma, Poole UK) at 2 J..lg/cm2, 0.2 J..lg/cm2 
and 0.002 J..lg/cm2 solution overnight at 4°C and washed three times in PBS 
prior to incubation with cells [30, 89-91]. After the results of the adhesion 
studies, POC scaffolds for Tencell experiments were then coated at the higher 
concentration of fibronectin. 
2.3.3 Seeding cells into non-porous POC films 
Myocytes were detached from the monolayer culture by enzymatic digestion 
with trypsin EDT A in PBS. This cell suspension was then centrifuged for 7 
minutes at 1,000 rpm (200 g, MSE Mistral 1000, Sanyo Biomedical Co. Ltd) 
and diluted in supplemented media to a concentration of 2 x 106 cells per mL. 
For the ECM protein study, coated POC films were seeded with lx106 HL-l 
cells/cm2, and incubated for 18 hours. After this time, films were washed three 
times in PBS for 5 minutes and analysed for survival using Live/Dead stain. 
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2.3.4 Seeding cells into porous POC scaffolds 
Myocyte concentrated cell suspensions of 320 x 103 and 2.2 x 106 cells per mL 
were prepared as described in Section 2.3.3. Coated POC scaffolds were 
seeded with either 160 x 103 for the seeding studies or 0.55 x 106 and 1.1 x 106 
HL-I cells for the Tencell studies. This constructs were placed in 6-well or 8-
well non-tissue culture treated plates or directly into Tencell bioreactor 
chambers. Constructs were incubated for 1 or 7 days. Afterwards, constructs 
were removed and analysed with Alamar Blue, processed for quantitative RT-
PCR(qRT-PCR) analysis and treated to be imaged by Stereo, Confocal and 
SEM. 
Static seeding 
For static seeding 500 ~ L L of the concentrated cell suspension was pippeted 
through each scaffold three times and allowed to incubate in a humidified 
incubator (37°C, 5% C02 in air) for 20 hours before imaging and analysing for 
survival. 
Centrifugal seeding 
POC scaffolds were placed at the bottom of 15 mL Falcon centrifuge tubes, 
one per tube, and 500 ~ L L of the concentrated cell suspension in 5 mL of 
supplemented media was added. Constructs were centrifuged at 1,000 rpm 
(200 g) for 7 minutes. Supematant was discarded and constructs were 
transferred to 6-well non-tissue culture treated plates and incubated in a 
humidified incubator (37°C, 5% C02 in air) for 20 hours. 
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Dynamic seeding 
For dynamic seeding, 500 ilL of the concentrated cell suspension was pippeted 
through each scaffold three times and transferred to an orbital shaker, in a 
humidified incubator (37°C, 5% C02 in air), to agitate at 100,200 or 300 rpm 
for 20 hours. 
2.3.5 Static culture 
Seeded scaffolds were transferred to either 8-well non-tissue culture treated 
plates or to Tencell static chambers. One scaffold was placed in each well or 
chamber containing 6 mL medium. Media was replenished everyday with fresh 
culture medium. Constructs were cultured for 20 hours or 1 week in either a 
humidified incubator or in the Tencell. 
2.3.6 Tencell culture 
The Tencell bioreactor was chosen to perform the dynamic culture due to its 
multi-station capacity and chamber geometry (Figure 2-3). Tencell was 
designed and custom-built at the Leeds University to culture constructs under 
uni-axial strain [92] (Leeds, UK). The work carried out in the Tencell was 
possible thanks to the collaboration of Professor Ingham and Joanne Ingram, 
from Leeds University, who kindly provided the device and the training, 
respectively. Briefly, the Tencell bioreactor was sanitised and then sterilised by 
UV light exposition whilst chambers and other components were sterilised by 
dry heat. Seeded scaffolds were mounted into the 16 chambers and assembled 
76 
F E 
• • 
• • 
• • 
• • 
• • • 
• • • 
• • 
• • D me=) B 
G H 
Figure 2-3 Diagram of the Tencell bioreactor 
Bioreactor includes (A) Air/C02 mix inlet (B) air/C02 mix outlet, (C) sterile water bath, 
(D) hotplate, (E) static/control group, (F) Mechanical stimulated group with coupling to 
adjust stretching at 10% and 1 Hz. Clamps (G) and constructs (H) are also shown. 
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in the stations. Stations 1 to 8 were kept static as control while stations 9 to 16 
were coupled to the uni-axial system to control the strain. 
The humidity chamber was filled with sterile water and each individual 
chamber was supplied with 6 ml of culture media, replaced everyday. The 
bioreactor was sealed and filled with 5% C02 in air and the controls were 
adjusted to provide the cyclic strain. Constructs were stretched 10% of 
amplitude (which considering the length of the scaffold being 30 mm, was 3 
mm) at 1 Hz either continuously or for 4 hours every day. Amplitude of 20% 
was also considered however due to constraints of equipment availability and 
time only 10% was performed. Construct were cultured for 1 week in the 
Tencell bioreactor at 37°C and 5% C02. Samples were then removed and 
processed for SEM microscopy, Alamar Blue, qRT-PCR and stained for 
LivelDead imaging. 
2.4 Biochemical and Molecular assays 
2.4.1 Alamar Blue 
The Alamar blue assay is a simple, sensitive. rapid and safe method to measure 
metabolic activity of mammalian cells and other organisms. This method can 
be used for cell suspensions or attached cells. This assay is based in the 
reduction of resazurin or Alamar blue (blue, non-fluorescent) into resorufin 
(pink, fluorescent), by metabolic cellular activity. The chemical reduction is 
quantified by either colorimetric or fluorescent evaluation. The medium was 
removed from the culture plate and the cells were washed with PBS. 1 ml of 
Alamar Blue working solution was added to the attached cells and incubated 
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for 90 min at 37°C protected from light. Alamar working solution was prepared 
by diluting 1:10 the lOx stock solution of Alamar Blue (Serotech). After 
incubation, 100 /-LI of the solution was transferred to a 96-well plate (Falcon) 
by triplicate per each of the three samples and read on the fluorescence plate 
reader (Cytofluor, Perceptive Biosystems) at 530nm excitation, 590nm 
emission. After Alamar blue assay, samples were washed in PBS and used for 
further analysis [93]. Cell number was calculated using the calibration curve 
for each cell type. 
2.4.2 Quantitative RT -peR 
First a-actin, J3-MHC and ANF were defined as the proteins of interest. 
Primers for the corresponding genes (actc1, myh6 and nppa, respectively) were 
designed for qRT-PCR as follows: the gene sequence was obtained from the 
NCBI Gene Bank. Because the SybrGreen technique employed for qRT-PCR 
is not selective for a specific DNA sequence, particular care had to be taken 
when designing primers for gene amplification. The forward primer was 
specifically located on an intron-exon boundary, so that the 5' half of the 
primer binds to one exon, and the 3' to the following exon. This resulted in the 
lack of binding to genomic DNA during PCR and thus in a selective 
amplification of cDNA. Primers were designed using the software "Primer3" 
[94-95]. This software calculates all the possible options and sort them out 
depending on the optimal primer length, melting temperature, specificity, 
absence of self-complementarity, G/C content, G/C and AIT distribution and 
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Forward 5895.8 NA 65.4 AGTGCAGGCGGAACAAGAC 
myh6 
Reverse 6034.8 63 .5 GGTCATCTCCTTCACCTTGG 
6731 .2 0.961 62.1 CTTTCATTGGTATGAATCTGC Forward 
aclcJ 
6461.1 63 .7 GCATACAGGTCTTTGCGGATA 
Reverse 
Forward 7047.5 0.959 63.2 TGGATTTCAAGAACCTGCTAGA 
nppa 
Reverse 5970.7 64.3 CCTGCTTCCTCAGTCTGCTC 
Forward 6133 0.974 64.1 AGTCCCAGCGTCGTGATTAG 
hprll 
Reverse 7584 63 .0 GGAATAAACACTrnTCCAAATCCT 
Forward 6077 0.96 63.9 GCAAGTTCCTGGTCCACAAT 
rpl32 
6101 63.3 TTGTGAGCAATCTCAGCACA 
Reverse 
Table 2-1 qRT-PCR primer sequences designed for mouse cells 
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the 3' -end sequence[94-95]. The primers were based on a target size of 80-1 00 
bp. Table 2-1 present the primer sequences for the qRT-PCR. 
Tencell samples were preserved in RNAlater at -80°C until analysis. 
Constructs were thawed and trypsinised prior to mRNA extraction carried out 
with the mRNA isolation kit (Miltenyi, UK) and then processed using the 
cDNA synthesis kit (Miltenyi, UK) to obtain the cDNA. This cDNA was 
mixed with 2 IlM primer solution (reverse and forward), SYBR green mix 
(Bio-rad, USA) and water. Samples were processed in triplicate in the iCycler 
Real-Time PCR Detection System (Bio-rad, USA). Samples were evaluated 
using hprtl and rpl32 as housekeeper genes. Relative expression levels were 
calculated using the results and the associated software REST 2005 [96-97]. 
2.5 Imaging of cells 
2.5.1 Evaluation of Cell Morphology and Contraction Rate. 
The morphology of the cells adherent to the surface was imaged using a 
LEICA microscope. A minimum of 100 cells from different passages were 
randomly chosen and photographed at high magnification (20x). Myocyte 
cross-sectional areas, length and width were measured by using an image 
analysis software package (Leica QWin, UK). 
For survival area, a number of live cells in a randomly delimited area were 
analysed by triplicate using the same image analysis package to calculate cell 
area coverage. For contraction rate, 25 cells from 10 T-25 flasks were 
randomly chosen and visually assessed with a chronometer. 
81 
2.5.2 Video recording of HL-l cells 
Contractile HL-l cells were video recorded using either a Canon Powershot SI 
camera (Canon, USA) or a UEye hi-speed camera (Micro-enterprises Inc, 
USA). Videos were edited and analysed using Windows Media Player and 
Windows Movie Maker (Microsoft Corp, USA). 
2.5.3 Immunofluorescence staining for sarcomeric-actin 
Immunofluorescence is a method used to visualise proteins by a specific 
immunological reaction between the protein or antigen and a conjugate. This 
technique can be used for fixed cells or tissue sections and is based on the use 
of fluorescent conjugates that will bind and stain the protein using a 
fluorescent microscope. Cells were washed in PBS and fixed in 4% PF AlPBS 
(Sigma, Poole, UK)for 10min, washed again and then permeabilised for 5 min 
with 0.1 % Triton X-lOO in PBS. Cells were washed before incubation in 4% 
normal goat serum (Dako, UK) for one hour. 
Samples were incubated overnight at 4°C with monoclonal goat anti-mouse 
anti-a-actin (Sigma, Poole, UK) diluted 1 :50. Samples were washed in 0.05% 
(v/v) Tween 20 in PBS and incubated with the secondary antibody, conjugated 
rabbit-anti-goat IgG-FITC diluted 1: 1 00 for an hour and then washed again 
with 0.05% (v/v) Tween 20 in PBS. Cells were washed with dH20 before 
mounting and visualising them under UV at ex/em 560/620 nm in a Leica 
DMBRI Fluorescence microscope (Leica, Microsystems Ltd., Bensheim, 
Germany) [98]. 
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2.5.4 LivelDead assay for Stereo and Con focal microscopy 
This assay is a two-colour fluorescence method that measures cell viability by 
simultaneously determining the number of live and dead cells. Live cells are 
coloured as intracellular esterases convert to fluorescent green the calcein 
acetoxymethyl (calcein AM) permeated into the cell through intact 
membranes. Dead cells are recognised as damaged membranes allow the 
reaction of ethidium homodimer-l and nucleic acids resulting in an intense 
fluorescent red colour. This method can be used to quantify live and dead cells 
or to visualise them under a fluorescent microscope [99]. Films or scaffolds 
were incubated for 30 minutes with 1.05 Ilmol/L caIcein AM and 4.0 Ilmol/L 
ethidium homodimer (LivelDead stain, Molecular Probes, UK) and then 
visualised under a fluorescent stereo and confocal microscope. POC films and 
scaffolds incubated in PBS were used as controls to assess the auto-
fluorescence of the material. 
2.5.5 SEM 
For SEM, biological samples are usually prepared to preserve the in vivo 
characteristics by dehydration and drying before being sputter-coated with gold 
[100]. POC constructs containing cells were processed prior to imaging under 
SEM. Polymer constructs were fixed in 3 ml of 3% glutaraldehyde and stored 
at 4°C in a sealed container. Glutaraldehyde was then removed and samples 
were washed in PBS. Constructs were covered with a 1% (v/v) osmium 
tetroxide solution and incubated at RT for 2 h before washing with dH20. 
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Samples were then serially dehydrated through ethanol solutions of 25%, 50%, 
70%, 90%, 95% and 100% (v/v) before incubating with HMDS and then 
allowed to dry at room temperature. Samples were sputter-coated as previously 
indicated in 2.1.3.1. The constructs were imaged in a JEOL JSM 6060 with an 
accelerating voltage of 10 and at a spot size of 40. 
2.6 Statistical analysis 
Normal distribution was confirmed by visual assessment, validating the use of 
parametric tests. For all data, except the qRT-PCR gene expression, the mean, 
standard error of the mean, variance and t-test of two tails, considering equal 
variances, were performed using Microsoft Excel 2002 (Microsoft 
Corporation, USA). 
For the qRT-PCR data, the software REST 2005 was used to generate the 
relative expression of the gene normalised with the reference gene as well as to 
calculate the standard error, the 95% confidence interval and the value of the 
probability of alternate hypothesis, difference between sample and control 
groups, was due only to chance (p) [97]. 
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3 Processing, Characterisation and Mechanical 
Properties of Poly-(1,8 Octanediol-Co-Citric Acid) 
[POC] Porous Scaffolds for Cardiac Muscle Tissue 
Engineering 
This chapter presents the synthesis of the elastomer POC and the efforts 
to process it into porous scaffolds for cardiac tissue engineering. The results of 
the subsequent characterization, including the macro and microstructure, are 
also discussed. Special emphasis is given to the mechanical properties and the 
biodegradability. 
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3.1 Processing Biomaterials into Scaffolds 
Several research groups are developing elastic biocompatible scaffolds for 
cardiovascular applications and for cartilage regeneration [10 1-1 02]. These 
elastomeric scaffolds are of special interest due to the need to mimic native 
conditions in vitro by applying external forces. Matching the mechanical 
properties of the host tissue has also been a concern and so new flexible 
materials have been developed. 
3.1.1 Polymers and elastomers 
Monomers are assembled sequentially through chemical reactions to produce 
large chains called polymers. Polymers are also classified depending on the 
reactions by which they were formed. Addition polymers are those obtained 
by addition reactions of free radicals where all atoms in the monomer become 
part of the chain. Monomers with two reactive groups continue extending the 
chain whereas monomers with only one terminal group usually result in low 
molecular weight polymers. Condensation polymers are synthesised in 
chemical reactions in which small by-products are released, usually water or 
methanol [34]. These polymers are formed by monomers with two different 
groups of atoms, capable of forming ester or amide bonds, resulting in 
polyesters or polyamides. 
Monomers with more than two reactive groups can link non-linearly, giving a 
three-dimensional structure. Cross-linked polymers often contain monomers 
with hydroxyl groups that covalently bonds to free ionised hydrogen atoms, 
triggered by high temperature or pressure. These polymers do not have 
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crystalline regIOns and therefore exhibit restricted molecular mobility. 
Copolymers, those with two or more monomers, are generally designed to 
modify the properties of the material to match a particular application. This is 
of fundamental importance in tissue engineering especially when the purpose 
is to work with cells in a mechanical environment to try to mimic the 
biological setting. 
Biopolymers are polymers that contain monomers found in biological 
processes and therefore can be degraded by metabolic pathways. Biopolymers 
are not only biocompatible to some tissues but can also display specific 
secondary or tertiary architecture to give spatial cues to cells [103]. As 
previously explained, elastomers are polymers with elastic properties that 
makes them useful for applications in the remodelling of tissues subject to 
mechanical activity. POC is one of the crosslinked elastic biopolymers 
reported with potential applications in tissue engineering. The processing of 
this material to obtain porous structures and their characterisation are the 
subject of interest in this chapter. 
3.1.2 Processing polymers into porous scaffolds 
Solid polymers are processed into different shapes and structures to specific 
needs. The complete range of methods used to modify polymers is described 
in the first chapter of this work. The methods used to process poly(I,8-
octanediol-co-citric acid) into porous scaffolds will be discussed here. 
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Gas foaming 
Gas foaming is also called supercritical fluid technology because it involves 
the use of a gas under supercritical conditions. Once a gas reaches above the 
critical point of temperature and pressure, the material no longer behaves as a 
fluid or as a gas but as both, with the density and solvating properties of liquids 
and the diffusivity and viscosity of gases. Supercritical fluids are solvents that 
have been used in extractions for different applications such as pharmaceutical 
and food processes, dry cleaning, chemical waste disposal and more recently as 
polymerisation catalysts. These fluids act as plasticisers modifying the 
viscosity, the glass transition temperature (Tg) or elastic modulus of the 
polymer without bonding permanently to it [102]. 
Carbon dioxide (C02) has been used in several supercritical applications 
because its low toxicity, flammability, cost, high availability and stability and 
low critical point conditions (304.1°Kl31.1°C and 73.8 barl7.38 MPa). CO2 
dioxide is one of the gases used as porogen to process polymers because it acts 
as a "clean" solvent on the material, replacing the need of an organic solvent 
[105-107]. When the pressure is released in the C02 supercritical system to 
reach ambient conditions, the diffused C02 dissipates through the polymer, 
"foaming" the material leading to a porous structure [108-110]. 
The creation of pores occurs in two stages, the first is the nucleation. Pores are 
formed because of the sudden pressure change modifying the solubility of 
CO2. During the nucleation, the diffusion of the gas defines the pore size; 
rapid release will produce homogenous pores as diffusion is minimal whereas 
slow release will induce a mix of large and small pores caused by the greater 
diffusion effect on the material [111]. After the pore formation, the 
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vitrification is caused by the change in the T g securing the pores and stabilising 
the structure [106,108-112]. 
The gas foaming method has been used and modified by several authors to 
produce porous structures. These alterations include the combination of gas 
foaming and salt leaching of NaCI particles to increase interconnectivity and 
avoid using high temperatures as Harris et al described in 1998 [113]. Several 
groups have been working towards the inclusion of bioactive molecules in 
scaffolds using supercritical fluids. Richardson et al reported the use of this 
technique as a method to integrate growth factors; Vascular Endothelial 
Growth Factor (VEGF) and Platelet-Derived Growth Factor (POGF) were 
processed into scaffolds without losing the biological activity [114]. Kanczler 
et al incorporated VEGF to poly(DL-lactic acid) (PLA) scaffolds and showed 
that after being exposed to supercritical conditions, this growth factor retained 
its angiogenic activity in vitro as well as ex vivo in an animal model [lIS]. 
Furthermore this method has been combined with a water-in-oil emulsion 
method, by Hile et ai, to include the basic fibroblast growth factor (bFGF). 
This group used the supercritical fluid to extract the organic solvent phase and 
to create the porous scaffold, although it was reported that the bFGF was 
deactivated by this process [116]. Proteins such as ribonuclease A and catalase 
were included in supercritical processed scaffolds by Howdle et al; results 
showed that protein structure and function were maintained and that the 
incorporation of thermo-Iabile molecules was possible by their novel process 
[117]. Supercritical scaffolds have also been exploited as a vehicle to deliver 
either cells or DNA to target tissues. Ginty et al reported the inclusion of 
mammalian cells such as C2C12 myoblasts, 3T3 fibrobalsts, chondrocytes and 
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hepatocytes into the supercritical process to create porous scaffolds. The 
constructs were created using either supercritical carbon dioxide or nitrogen; 
both methods resulted in scaffolds with viable cells. Although the cell survival 
did depend on the cell type, Ginty et al demonstrated that there was a 
maximum time that cells could be exposed to supercritical conditions before 
losing metabolic activity [118]. Heyde et al combined DNA and PDLLA to 
develop a non-viral DNA release system for tissue engineering applications. 
An aqueous solution of polymerlDNA complex was placed on top of PDLLA 
powder and freeze-dried the mix for 48 hours prior to processing it in SCC02. 
Even if transfection ratios varied depending on the DNA cryoprotectant, they 
were superior to those of commercial DNA release products. This method 
offered the benefit of a slow and continuous delivery of DNA in a localised 
area due to the DNA being encapsulated in the scaffold during the scC02 
process [119]. 
ScC02 was used to foam POC under different conditions as described in the 
Materials and Methods section. 
Solvent casting / Particle leaching 
The particle leaching method has been widely used to fabricate porous three-
dimensional scaffolds from biodegradable polymers. In this work sodium 
chloride, of a minimal diameter of 312 J..lm. was used as a porogen and it was 
added to a solution of POC/acetone. After the solvent was evaporated, the 
mixture of polymer and porogen was allowed to crosslink overtime. Once the 
polymer was crosslinked, this structure is immersed in water to leach out the 
salt, leaving the porous matrix to be used as a scaffold. Salt leaching produces 
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scaffold with high porous ratio and good interconnectivity; however the 
polymers processed by this procedure are restricted because of the solvent 
phase [120]. 
Different alterations of the general method have been adapted including 
solvent merging! particle leaching and salt fusion. Liao et of utilised a 
cylindrical Teflon mould with a leach that allowed the use of negative pressure 
to wash the organic solvent after dissolving the NaClIPLA mix. This 
configuration also permitted the pass of a non-solvent to precipitate the matrix, 
and of distilled water to leach out the salt and create the porous structure. This 
technique was reported to be quicker and easier than the conventional 
approach. In addition to this, it was possible to carve different structures from 
the large porous scaffolds depending on the application [121]. Murphy et al 
modified the method forcing crystal fusion by exposing the porogen, NaCI, to 
95% humidity for 0-24 hours prior to solvent casting. This change resulted in 
a highly interconnected matrix with internal bridges between pores and 
increased pore diameter and sphericity. These results also showed that the 
compressive modulus is increased for those scaffolds with exposed humidity of 
24 hours [122]. 
3.1.3 Methods for scaffold characterisation 
Micro-computed tomography (microCT) 
Micro-computed tomography is a method that uses X-rays to recreate virtual 
2D and 3D models of specimens. This technology does not damage the 
original sample nor requires prior preparation, and therefore can be used in 
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living and inert models. MicroCT is a variation of the original tomography 
equipment designed for medical scans, but the resolution is higher as micro 
refers to the precision of the technique. 
The device used for this technique, the Scanco JlCT40, is a closed x-ray system 
with a cone-beam imaging system of 2D x-ray detector, or still cameras, and 
one electronic x-ray source that creates and collects the cross sections images 
that can be reconstructed later into static or dynamic 3D models [123]. 
Microtomography has been used to evaluate and characterise the structure of 
materials and polymeric scaffolds in tissue engineering but also to monitor 
morphological changes of constructs and its micro-architecture [124-125]. 
Scanning Electron Microscopy (SE M) 
Scanning electron microscopy has been used to characterise materials. Macro 
and microstructure can be determined as it is not only possible to analyse 
shape and porosity but also pore size and interconnectivity. SEM is a standard 
technique to analyse surface morphology because it enables the 
characterisation of solid materials as well as porous structures. In the case of 
scaffolds, it is a concern that the biological performance may be altered by the 
material characteristics and so this information allows to modify the material 
to adapt for the needed response. As this type of microscopy requires a dried 
and metal coated sample, it must be considered that this technique may alter 
the morphology, especially on materials that undergo changes in hydrated 
conditions [126-127]. 
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Pycnometry 
Helium pycnometry is a non-destructive technique that allows the quantitative 
analysis of porosity through the measurement of volume and true density of the 
samples; these are calculated using the Archimedes principle of fluid 
displacement and the Boyle's law. In this instance the displaced helium can 
infiltrate the porous material giving the true volume and then comparing this to 
the geometrical volume [128]. 
Equations 3.1 and 3.2 were used to calculate the density (Ppycnometry) determined 
by pycnometry and the density (Pgeometr;c) determined by geometric 
(weight/volume) analyses using a micrometer screw gauge and scales [31]. 
Ptotal = (l-PgeometricA>bulk) x 100 
Pclosed = (l-(Ppycnometry !Pbulk) x 100 
3.1.4 Mechanical properties of scaffolds 
Equation 3.1 
Equation 3.2 
The mechanical properties of a material define its behaviour under a load and 
refer to the type of forces or stress that the material can resist. These 
properties include the strength, hardness, toughness, brittleness, ductility, 
malleability, elasticity and plasticity of the material. The mechanical 
properties of scaffolds are relevant not only in constructs that will be subject to 
dynamic culture systems but also for structures in static systems. These are 
important as the constructs will be implanted into living beings and therefore 
need to support the natural strain of the native tissue and surroundings. Tissue 
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engineering scaffolds must withstand types of stress such as tension, 
compression, impact, fatigue and in some cases shear and torsion. 
Because a cardiac implant will need to meet the stretching physiology of 
cardiomyocytes, the most important mechanical characteristics of a cardiac 
scaffold are the fatigue and elasticity. Fatigue is the property that enables the 
material to resist continuous stresses and is assessed by the number of cycles 
that the material can resist this stress. Elasticity is the ability to return to its 
original shape without permanent deformation once the stress has been 
removed. This is evaluated by measuring the tensile stress that the material 
can bear before reaching the limit of load of permanent deformation. Elasticity 
is determined by parameters such as maximum elongation and Young's 
modulus. Maximum elongation is the greatest deformation of the specimen 
before failure. The Young's modulus or elastic modulus, E, is a constant that 
quantify the stiffness of the material and is defined as the ratio of change of 
small stress to strain as described in the equation 3.3. 
E=F* Lo 
Ao *AL 
Equation 3.3 
Where E is the Young's modulus or elastic modulus, F is the force applied to 
the object, Lo is the initial length of the material before the load is applied, Ao 
is the original cross-sectional area through which the force is applied and L1L is 
the change of length once the stress was applied. In his project, the scaffolds 
were tested by applying a tensile load uniaxially and measuring the elongation 
of the elastomers. The engineering Young's modulus was calculated in all the 
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cases with software based on the previous equation, which also can be 
described as 
E=g 
&' 
Equation 3.4 
where (J' is the stress or load per unit of area and strain (8) is the change of 
length divided by the original length. As stress is a pressure, its international 
units are Newtons per square meter (N/m2) or Pascal (Pa); whereas the strain is 
dimensionless [34]. The physical state of a material defines its elasticity. 
Materials in a glassy state are stiffer and therefore E ranges in the thousands of 
MPa whilst rubbery materials have a lower E, between 0.1 and 10 MPa [129]. 
Elastomeric polymers, as most of the rubbers, present an unusual behaviour as 
seen in Figure 3-1. Contrary to other polymers that exhibit different regions in 
the stress/strain curve including a linear portion, elastomers display a large flat 
section which means that after an initial elongation there is region of stretching 
which occurs without increasing strain. 
Mechanical properties of porous materials vary widely from those of the solids 
as they depend on the porosity and pore size. However, when designing a 
scaffold it is required to guarantee mechanical strength as well as high 
porosity. Pores weaken the structural strength in a non-linear proportion 
depending on the density of the structure, for this reason, homogeneity of pore 
size is important to maintain a high density and not negatively affect the 
mechanical strength [130]. 
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Figure 3-1 Elastic behaviour oCpolymers and elastomers 11191 
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Several equations have been used to empirically assess the relationship 
between the elastic modulus of a solid material and the one of its porous 
structure as can be seen in Equation 3.5. 
E=Eo *(l_p/pJI Equation 3.5 
where E is the Young's modulus of the porous material with porosity p, Eo is 
Young's modulus of the solid material, pc is the porosity at which the effective 
Young's modulus becomes zero and f is the parameter dependent on pore 
geometry (pore size and closed pores) and grain morphology (grain size and 
cracks) of the material. The value of pc is often considered as 1, while the 
value of fin linearised models is one [131] 
When materials are cyclically stressed at the same point over a long period of 
time, they frequently fail on conditions below their maximum load or tension. 
This fatigue, along with the fracture and failure of porous materials are 
influenced by imperfection and internal flaws in the structure such as cracks, 
notches and large pores [130, 132-133]. 
Mechanical properties such as strength can be altered by combining other 
materials. Cellulose has been reported as a biodegradable polymer suitable for 
scaffold fabrication for hard and soft tissue engineering, including cartilage 
[134-136]. Still the major challenge of a homogeneous biodegradable 
elastomeric composite with optimum biological and mechanical properties is 
unresolved. 
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3.1.5 Degradation 
Polymer degradation is defined as the deteriorative change of properties in a 
material caused by physical (heat, light and radiation), biological, chemical 
(including pollutants, oxidation and hydrolysis) or mechanical stress. Oxygen, 
hydrolysis and biological action are the most common causes of degradation of 
scaffolds. Degradation is desired in some biological systems as the release of 
monomers allows the reduction of molecular weight and facilitates the disposal 
by biological pathways [137]. However, degradation of a scaffold also means 
that the mechanical properties may be compromised. The challenge when 
designing a polymer is to obtain a polymer that will last enough to support the 
remodelling of the area but will eventually degrade and disappear from the 
host. 
When implant materials interact with biological surroundings, either the 
material loses molecules to the environment (leaching) or takes up foreign 
fluid into its structure (swelling). This diffusion phenomenon affects the 
mechanical properties of the material. Swelling limits the elasticity and speeds 
up the failure whilst leaching can diminish the elasticity due to the voids but 
also has a major impact, as degradation products can trigger local and systemic 
responses from the biological host [138]. Because of this, it is of major 
importance to characterise the degradation profile of the materials used in 
tissue engineering. There are few reports of the degradation of POC in-vivo 
and in-vitro and therefore this work also focused part of this chapter to that. 
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3.1.6 Aims of this study 
The aims of this study were to find a suitable method to process poe into 
porous structures. The mechanical properties of the resultant 60%, 70% and 
80% porous poe and POe-cellulose films were investigated after different 
storage conditions. The elastic modulus as well as the maximum elongation 
and force at break were evaluated with the stress/strain curves resulting from 
tensile tests. 
3.2 Materials and methods 
3.2.1 Synthesis of POC 
The poe was synthesised as described in 2.1.1. Briefly 109 of citric acid 
powder were mixed with 7.61 g of 1,8-octanediol in a round-bottom flask. The 
stirring mixture was melted at 1600 e and then polymerised at 140oe. The 
resulting polymer was cast into moulds and allowed to cool down before being 
crosslinked at different times. Alternatively poe was dissolved in acetone to 
30% (v polymer/v solvent) to prepare the polymer solution needed for the salt 
leaching method. 
3.2.2 Gas foaming of POC 
The poe discs (10 mm diameter, 8 mm thick) were placed into high pressure 
vessels and foamed as described in section 2.1.2.1 
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3.2.3 Salt leaching of POC 
The POC polymer solution was mixed with NaCI, in proportion to the porosity 
required and cast into a mould. After the solvent was evaporated the polymer 
mix was crosslinked as described in 2.1.2.2 for 2 weeks and washed in PBS for 
3 days to dissolve the porogen and create the porous structure. 
3.2.4 Characterisation of POC scaffolds 
Scanning electron microscopy was used to observe the cross-sectional pore 
morphology of the scaffolds and to detennine pore size. Samples were 
mounted on an aluminium stub and sputter-coated with gold. SEM 
observations were carried out at 20 kV as described in 2.1.3.1. 
MicroCT was used to detennine pore size and porosity as detailed in 2.1.3.2. 
Porosity was evaluated by helium pycnometry using equation 2.1 and 2.2 as 
explained in section 2.1.3.3. 
The tensile tests to generate the mechanical data for the specimens were 
carried out as described in 2.1.3.4 and the degradation studies followed the 
method specified in 2.1.3.5. 
3.3 Results and Discussion 
POC was processed into porous scaffolds using two methods. Results were 
analysed in order to select the most advantageous method for a rapid 
manufacture of poe scaffolds. These structures were then analysed for pore 
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SIze, porosity and mechanical properties under different composition and 
storage conditions. 
3.3.1 POC processing 
POC was synthesised as previously described in 3.2.1 according to a previous 
published work; the physical characteristics of the material were determined by 
the crosslinking time. Crosslinking times of 3 and 7 days and temperatures of 
80DC and l20°C were compared. When POC was cross linked for only 3 days 
at moderate temperature, the polymer was not crosslinked enough to solidify 
and the elastomer remained a transparent viscous slurry. However, when POC 
was crosslinked at higher temperatures for the same period of time, it resulted 
in slightly stiff yellow discs. POC crosslinked for a longer period of time, 7 
days, at moderate temperature (80°C) resulted in elastic discs, whilst higher 
temperature (120°C) produced "over-crosslinked" stiffer orange discs. The 
resulting solid discs can be seen in Figure 3-2. 
The higher the level of cross linking, the stiffer a polymer becomes. Previously 
it has been reported that crosslink density affects the strain-hardening. 
Yamaguchi et al found that an increased crosslink density restrained the chain 
stretching and therefore affected the strain hardening and other rheological 
properties [139]. 
Supercritical Carbon Dioxide Processing 
Once the polymer was synthesised, supercritical foaming was chosen as a 
processing method to obtain porous scaffolds. Previous work has demonstrated 
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Figure 3.2Digital images of POC discs crosslinked for (A) 3 days at 120°C, (B) 7 days at 
120°C and (C) 7 days at 80°C 
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that supercritical technology can produce highly open porous structures when 
applied to certain polymers [105-113]. As POC is a relatively new polymer, 
there is no prior experience of this material processed in scC02 and therefore 
the two main parameters of the system, venting and soaking time, were 
modified to produce a porous scaffold. POC was placed in TEFLON moulds 
to control the shape of the resulting scaffold and then located in the pressure 
vessel. Venting time was maintained short to create homogeneous porous 
structures whereas the soaking time was increased starting from 15 minutes to 
30 minutes, 2, 4, 6, 8, 12 and 16 hours. POC processed for less than 8 hours 
showed a slightly foamed exterior in the top of the disc but no change at all in 
the internal structure as can be seen in Figure 3-3. When time was increased to 
8 hours, the core of the polymer cylinder was partially foamed but. It was 
decided to increase the soaking time to obtain a total porous structure. POC 
processed for 16 hours in the supercritical C02 system resulted in a foamed 
scaffold as can be seen in Figure 3-4. 
One of the advantages of using scC02 is the short exposure times to foam a 
polymer Gust five minutes), which allows incorporating live cells and thermo-
labile bio-molecules [117-119]. In order to understand why POC needed 16 
hours to be foamed thoroughly, both monomers were subjected to scC02 
separately; it was found that none of these were soluble in C02. It has been 
previously discussed that only high amorphous and non-crystalline polymers 
dissolve in supercritical fluids and therefore foam when the pressure is 
released. Also, high molecular weight polymers with long chains resist 
expansion during foaming [112, 140]. 
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Figure 3-3Digital images of (A) non processed POC disc compared to porous POC structures processed by scC02 for 2 hours, foamed only in the superior part of 
the disc. (B) POC processed for 4 hours compared to an untreated disc and (C-D) fully foamed POC discs after 16 hours of supercritical processing. 
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Figure 3-4 SEM images of (A·B) POC discs crosslinked for 10 days and processed with scC02 for 6 hours showing solid internal structure with pores only in the 
surface. (C-D) POC crosslinked for 14 days and then foamed for 6 hours showed the same effect with a resultant solid core. 
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In addition to the long hours needed to treat poe discs, the supercritical 
method is carried out in a pressure vessel which limits the number and shape of 
Teflon moulds used. 
Mechanical conditioning of POC scaffolds requires a rectangular shape rather 
than cylindrical scaffolds. In addition, processing poe with SCC02 would 
mean that only one scaffold was produced every 24 hours. Although 
supercritical fluid is a solvent free technology used to create porous structures, 
unfortunately in the case of poe, this was not a suitable method and was not a 
cost/time-efficient method. Furthermore the limitation of shape, size and 
number of scaffolds created per batch made the gas foaming technique not 
adequate for this project. 
Salt leaching 
Salt leaching was tested as an alternative method to SCe02 foaming to produce 
porous scaffolds. This method is an easy technique restricted only by polymer 
solubility. Due to the concern of residual solvent toxicity, solvents are best 
avoided when processing scaffolds for clinical applications. As the use of 
solvents is indispensable in this case, a mild toxic solvent, acetone, was used. 
Polymer was crosslinked for 2 weeks, with 20%, 30% or 40% salt and then 
washed out in subsequent washes with dH20 for 4 days. 
Salt leaching produced highly porous poe discs as can be seen in Figure 3-5; 
porosity and pore size was confirmed using SEM as described with more detail 
in section 3.3.2. This method allowed the fabrication of different forms and 
sizes, as the final morphology depended on the mould used to cast the scaffold. 
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Figure 3-5 Digital images of (A-B) salt leached POC discs of 10 mm diameter and 8 mm thick. Magnified images of (C) pores shaped like the porogen and (D) 
interconnected pores 
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Teflon moulds were customised to assure the rectangular shape needed for the 
stretching bioreactor (Figure 3-6). Whereas POC discs were highly porous and 
homogenous, POC rectangular films proved to be heterogeneous with 
porosities greater than 80%. An initial effort to fabricate POC porous films of 
90 and 95% porous demonstrated that they were not homogeneous because of 
the large open area in the mould. Previously it was reported that scaffolds for 
tissue engineering ideally should be 90% porous or more. However in the case 
of POC large films this was difficult to achieve and the scaffold was 
mechanically compromised due to its shape and hence could not sustain the 
strain intended for this application. Three different porosities were designed 
for the films: 60, 70 and 80%. The weight/volume of the porogen was 
considered in order to assure the porosity intended for films and confirmed 
after porosity analysis. 
This technique produced well interconnected porous scaffolds as was 
confirmed by SEM and microCT (Figure 3-7 and table 1-). 
Due to the concern of achieving the required mechanical strength, it was 
considered to incorporate cellulose to strengthen the films. Entcheva et al 
reported the use of cellulose acetate fibres to culture cardiac cells. Cellulose is 
considered as a biomaterial due to its biodegradability although a non-
mammalian enzyme, cellulase, is needed to break it down to glucose. Results 
showed that cellulose supported cardiomyocyte growth and physiology [136]. 
An initial approach of incorporating 10% (w/w) of cellulose was used in the 
same salt leaching technique to produce 60%, 70% and 80% scaffolds. 
It was found that water vapour bubbles were created and trapped within the 
polymer during crosslinking. These bubbles did not completely escape from 
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Figure 3-6 Digital images of Tenon moulds and the resultant POC discs and rectangular films after solvent casting process 
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Figure 3-7 (A-B) SEM and (C-D) microCT images of salt leached POC 70 % porous scaffolds confirming fun porous structure and interconnectivity 
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the structure and therefore the surface was left with large holes on the upper 
side. In an attempt to avoid this, the acetone was cooled to slow down the 
evaporation process but the end result was the same. Although these apertures 
could weaken the scaffold mechanically, it was hypothesised that at the same 
time they could facilitate cell seeding and mass transfer once in culture. 
3.3.2 POC scaffold characterisation 
POC scaffolds were characterised to establish the suitability of these structures 
for cardiac culture. Morphology, porosity, pore size, pH in aqueous media, 
mechanical properties and degradation were assessed as reported below. 
Morphology 
Scaffold morphology of POC films matched that of the mould in which they 
were cast: 56 mm of length, 24 mm of width and 2.5 mm of thickness. 
Porosity 
The weight/volume of the porogen was considered in order to assure the final 
desired porosity for films. This calculated porosity was confirmed by microCT 
and helium pycnometry. As discussed before it was used three different 
porosities, 60, 70 and 80%. These porosity values may influence cell 
attachment and proliferation, as the porosity increases the cells have more 
space to spread and to improve diffusion of nutrients and oxygen. In contrast, 
the less porous the structure, the more difficult it is for cells to infiltrate and 
populate the construct; although that would offer better mechanical properties. 
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Therefore a compromIse had to be reached. Porosity of POC and 
POC/cellulose scaffolds stored at room temperature and at -20°C was assessed. 
Analysis of microCT images (Figure 3-8) showed that there was a minimal 
variation between the real and the theoretical porosity. Porous scaffold with 
theoretical porosity of 60% reported a porosity of 61.06 ± 1.20% when 
analysed by microCT and of 61.04 ± 5.42% when pycnometry was used. 
Insignificant differences were also found in 70 and 80% porous scaffolds as 
can be seen in Table 3-1. This table also shows the results of Helium 
pycnometry which confirms the porosity of the scaffolds. SEM showed that 
the scaffolds are not totally open-porous but with a porous structure that will 
be able to host the cardiac cells (Figure 3-9). 
Pore size 
Characteristic distribution of pore size in these scaffolds showed a peak around 
the value of the porogen size. Larger pore sizes were due to the creation of 
bubbles in the structure. The mean pore size of 70% porous scaffold, as 
determined by microCT, of 365 microns was greater than the average of 242 
microns found with the SEM (Table 3-2). Mean pore size varies between 
microCT and SEM analysis, mainly because SEM only considered random 
transversal images of the microscopic pores whereas the microCT evaluation 
includes the average of the void fraction, offering a thoroughly analysis. 
Typical distribution of pore size for 60%, 70% and 80% porous POC scaffolds 
stored at room temperature are shown in Figure 3-10 whereas those stored at -
20°C are in Figure 3-12. The same microCT analysis was performed for 
POC/cellulose scaffolds (Figure 3-12). 
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(A) (8) (C) 
(H) (I) 
Figure 3-8 MicroCT images from sections of (A) 60%, (B) 70% and (C) 80% porous POC scaffolds stored at room temperature; (D) 60%, (E) 70% and (F) 80% 
POC porous scaffolds stored at -20°C and of (G) 60%, (H) 70% and (I) 80% POC/cellulose scaffolds stored at room te 
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Figure 3-9 SEM images from sections of (A) 60 %, (8 ) 70 % and (C) 80 % porous POC scaffolds stored at room temperature; (D) 60 %, (E) 70 % and (F) 80 % POC 
porous scaffolds stored at -20°C and of (G) 60 %, (H) 70% and (I) 80 % POClcellulose scaffolds stored at room temperature 
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60% 61.06 (± 1.20) % 61.04 (± 5.42) % 
70% 69.56 (± 2.59) % 71.67 (± 1.04) % 
80% 80.80 (± 1.17) % 79.33 (± 0.81) % 
Table 3-] Porosity of poe scaffolds (n=3 for microCT; n=9 for He pycnometry) 
365.66 (± 16.25) 242.33 (± 41.54) 
Table 3-2 Mean Pore size (StDev) of POC scaffolds (n=3 for microCT; n=9 for He pycnometry) 
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Figure 3 Histograms of pore size distribution of (A) POC scaffolds, (8) POC freeze-dried 
and (C) POC/cellulose. Data obtained from microCT analysis of POC scaffolds 60% 
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116 
FOC70% 
A 
1 1 ~ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
5i I 
~ ~ 5 ' 
~ 1 1 ~ ~
~ ~ 0 - ' - ; - ! - -n \ ' - ' '~ ~ 'l'!-'l-'1-'I'I-\''I-'I'I-'''!-'ll'-'!-'I'I-\f-''-'I'I-''-'P{'!'-'I-'I-\''/-'I-'I-'I'Pf'!-'l'l-'P.''PI'I-''''''''''''''''''''''f'''rT>c-I-'rr 
<:) , , ~ ~ ' 1 - ~ ~ ~ < : ) ) ~ < : ) ) ~ < : ) ) rS><:) ' \ ~ ~ C ( ) ~ ~ # ,,# ",,<:)<:) ,&'<:) 
[lameter [micrometers] 
B FOCFD70% 
20 .----------------------------------
Cl) 15 
Cl 
110 
~ ~ 5 
o 
<:) ~ ~ ' 1 - ~ ~ ~ < : ) ) ~ ~ <# rS><:) ' \ ~ ~ ~ < : ) ) # ,,# , , ~ ~ , , ' 1 - ~ ~
[lameter [micrometers] 
c FDC-cellulose 70% 
2 2 ~ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
20 +--11--------------------------------
(lameter [micrometers] 
Figure 3-11 Histograms of pore size distribution of (A) POC scaffolds, (B) POC freeze-
dried and (C) POC/cellulose. Data obtained from microCT analysis of POC scaffolds 
70% porous. 
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Mean pore size of POC scaffolds was not significant different from each other 
regardless of the storage method or the cellulose inclusion (Table 3-3). Pore 
size could also be modified by altering the porogen size. In that case the SEM 
revealed an adequate pore size to culture cardiac cells due to the size of 
cardiomyocytes. 
Density 
Density was calculated after weighting five samples of each randomly and 
considering the volume of the scaffold. Porosities calculated by the density are 
consistent with the theoretical porosity. Table 3-4 shows the density of POC 
scaffolds at different porosities, variations were not significant. These density 
values also matched the porosity values compared to the solid density of the 
polymer. 
Density has an inverse relationship with porosity. High porosities mean a 
reduced amount of polymer in the structure and therefore a lower density. 
pH neutralisation 
POC and POC/scaffolds exhibited a low pH of 4.0 ± 0.4, unsuitable for 
mammalian cell culture. Further studies revealed that acidic residues were 
present after salt leaching and that degradation was also triggered by the dH20 
washes. Acidity was buffered to physiological levels by washing subsequently 
with PBS. The pH neutralisation in small volumes of buffer washes, 100 ml 
per scaffold, took more time than when washed in large PBS volumes, 4 litres, 
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Co:\ ()J 110:\ POIU: SIZE (S'I DE\) 
Stored at room temperature 242.33 ± 41.54 
Stored at -20°C 269.33 ± 9.50 
POC/] 0% cellulose scaffolds 255 ± 38.43 
Table 3-3 Pore size between RT, -20, + cellulose (microCT) (n=3 for microCT; n=9 for He 
pycnometry) 
DI.'\sll'l [g 'cm31 POROSII'l 
Solid POC 1.2469 ± 0.0147 
60% 0.4746 ± 0.01929 61.94% 
70% 0.3781 ± 0.0079 69.68% 
80% 0.2582 ± 0.0050 79.27% 
Table 3-4 Density of POC scaffolds at different porosity values (mean values ± SO, n=3) 
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as is presented in Figure 3-13. After stabilising the pH, scaffolds were freeze 
dried and stored, either at -20°C or at room temperature. Another approach to 
clear the acidic remains of the polymerisation include the use of supercritical 
fluids to wash the undesirable residual monomers; unfortunately, as mentioned 
before, both monomers were not soluble in scC02 and therefore this method 
was ineffective (Figure 3-14). 
Degradation profile 
The construct was designed to be used as an implant and therefore it is 
required to study the degradation profile, how long will it last inside a host and 
how long will it support the seeded cells. It is also important to see if there 
was an excess of by-products that could trigger immunological responses. 
POC scaffold are hydrophilic and when placed in aqueous solution they 
absorbed water and swelled, increasing their volume up to 30%. This large 
swelling degree is comparable to collagen as reported by Radisic et al [70]. 
Initial leaching out and pH buffering washed the remaining acidic residues in a 
process that is not considered as degradation. 
Rapid degradation by hydrolysis was observed as scaffolds lost around 25% of 
their weight in the first four weeks. Degradation slowed down on the second 
and third month losing 10% in average; however the final stage of degradation 
was rapid again from the fourth month, when only 18-28% of the scaffold 
remained. The majority of the scaffolds were a thin jelly-like film by the 22nd 
week, whereas by the 25th week most of them were totally degraded. 
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Figure 3-10 pH neutralisation of a POC scaffold washed in (A) 100 rnl and (B) 4,000 rnl of 
PBS 
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Figure 3-11 pH variation of POC scaffolds washed in scC02 compared to untreated POC 
scaffolds overtime 
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Also, as can be seen in Figure 3-15, 80% porous POC scaffolds showed a 
slightly faster degradation profile than 60% and 70% porous scaffolds, 
although no significant difference was observed. MicroCT analysis of samples 
during the first two weeks revealed little change in the morphology of the 
scaffolds. However after four weeks, it was observed that the loss of weight 
was caused by both bulk and surface degradation. Figure 3-16 shows microCT 
images of these scaffolds at different degradation point times, including the 
residual solid films after 26 weeks. 
Degradation ratio was affected by the geometrical shape and by the porosity. 
Compact cylindrical scaffolds degrade slower as the mass transfer to the inner 
core of the disc takes longer than in rectangular films, where a major area is 
exposed to the environment. Overall, these flexible scaffolds exhibited a quick 
degradation. Cardiac patches are expected to endure a couple of months, which 
in addition to the previous weeks, when the material was processed and 
conditioned, it would be expected to maintain its integrity for at least three 
months. A slower degradation profile could be tailored by increasing the 
crosslinking of the polymer. 
Mechanical properties 
Previous works on the mechanical properties of non-porous POC films 
reported that the elastomer has an ultimate elongation of 260% and a Young's 
modulus of 2.6 MPa [41]. However scaffolds fabricated with POC for soft 
tissue application showed a decreased elongation of less than 100% and a 
Young's modulus of 0.5 MPa [141]. 
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It was found that after processing, the mechanical properties of these scaffolds 
were weakened by the presence of pores, POC films exhibited a Young's 
modulus that ranged from 1.5 to 3.3 kPa. Alterations in the Young's modulus 
were observed when the strain rate and the porosity were modified. An 
increment of the strain rate during the tests exhibited an increased Young's 
modulus in all the specimens. This is congruent with this elastomer, as an 
augmented strain rate equals a lower temperature and therefore a stiffer 
material. In addition, the Young's modulus decreased in scaffolds with higher 
porosity, from 3.5 KPa - 1.5 kPa for 60% - 80% porous scaffolds respectively, 
all stored at room temperature and tested at 500 mmlmin (Figure 3-17). This 
was attributed to a reduced proportion of solid material in the scaffolds and a 
high percentage of voids due to pores weakening the mechanical properties 
resulting in less stiff structures. 
The differences in the Young's modulus between scaffolds stored at room 
temperature and at -20°C were probably due to continued cross-linking during 
storage at room temperature, which did not occur at -20°C. The stiffness of 
the left ventricle of the heart has been calculated at 31 kPa [142], which is 
higher than the values found for this porous polymer scaffold. This suggests 
that this material is more flexible than the heart and that could be suitable for 
use in cardiac tissue engineering as long as the maximum elongation and the 
fatigue values matches those of the native tissue. Studies using other 
biodegradable elastomers have reported similar mechanical properties to 
proteins found in human tissues. Wang et al. synthesised a biocompatible 
biodegradable-elastomer, poly(glycerol-sebacate) (PGS), that exhibited a low 
Young's modulus of 0.28 MPa and a minimum elongation of 267% [143]. 
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Flexible Poly( esther urethane )urea (PEUU)/Collagen scaffolds were 
electrospun by Stankus et al. to assess the effect of collagen concentration on 
the mechanical properties of this soft material. A decrease in the tensile 
properties from an initial modulus of 8 MPa to 2 MPa was found in scaffolds 
with 90% content of collagen, but the breaking strain was increased from 
220% to 270% [144]. Soft materials with high strain such as PGS, PEUU or 
POC can be exploited for soft tissue applications, whereas other elastomeric 
polymers such as P4HB, with a high elastic modulus of 250 MPa may not be 
suitable for this [145]. There are few reports on the mechanical changes of 
biodegradable elastomeric scaffolds over time. In a recent paper, Guan et al 
reported the use of porous PEUU scaffolds for soft tissue engineering. These 
biodegradable polyurethane scaffolds exhibited breaking strains from 214 to 
294% and tensile strength of 0.97 to 1.64 MPa but most importantly it was 
shown that their mechanical properties decreased after two weeks to a breaking 
strain of 150% and a tensile strength of 0.8 MPa due to polymer degradation 
[146]. 
These scaffolds, which presented a maximum elongation at break between 
60% and 160%, were used to culture cardiomyocytes within a stretching 
bioreactor for which it was wanted to generate a material with a minimum 
elongation of 20%, based on previous studies [147]. Although the maximum 
elongation of the human heart varies from 20-90%, the average is 60% [148-
149]. As can be seen in Figure 3-18, POC scaffolds achieved 60% of 
maximum elongation as a minimum and therefore this material complies with 
the physiological parameters required for cardiac tissue engineering. 
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The suitability of this novel scaffold for cardiac engineering is focused on its 
porosity, which would allow increased mass and oxygen transfer to that of 
sheet cell cultures commonly used in cardiac tissue engineering. Benefits also 
include the tailoring of geometry, pore size, degradation rate and mechanical 
properties. 
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3.4 Conclusions 
Physical and mechanical characteristics of a tissue engineering scaffold are of 
major importance as it must withstand the environmental stresses and strains 
that the native tissue undergo. These must be true to nonnal conditions but also 
during healing and remodelling processes. This chapter presents the 
processing of poe into porous structures to fabricate elastic scaffolds using 
two different methods. Table 3-3 shows the advantages and disadvantage of 
these methods. poe is a novel polymer which can be processed into porous 
structures to host mammalian cells. The micro-architecture of such scaffolds 
can be tailored in accordance to the target tissue. High porosities can be 
achieved in cylindrical scaffolds whereas films are restricted to porosities no 
higher than 80% in order to guarantee its mechanical strength. Pore size does 
depend on the processing method. In the case of salt leaching, porogen size 
and morphology detennined pore size distribution. The rectangular films 
designed to match the dynamic bioreactor were easily produced and 
differences between batches were not significant. Although the elastic 
modulus was lower than expected at each porosity, the elongation was superior 
than anticipated in all the cases. Altogether the mechanical properties 
exhibited, allowed the use of these scaffolds for cardiac culture in a stretching 
bioreactor. The degradation profile revealed that the constructs must last until 
the regenerated tissue populate and take on its structural role. It is expected 
that the mechanical properties of the construct will decreased more rapidly 
overtime when it is subjected to cyclic strain than during static culture as 
observed by Boublik et al [150]. 
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Supercritical - Clean technology (no use of - Limited materials 
carbon solvents) suitable 
dioxide - Allows incorporation of bio- - Restricted geometry 
molecules and cells - Small production batches 
- Easy to process - Use of solvents is 
Salt leaching - Allows pore size, porosity required 
and mechanical properties - Heterogeneous structures 
tailoring in large pieces 
Table 3-3 Advantages and disadvantages of methods used to process POC 
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4 Optimisation of seeding conditions for myocytes in 
Poly (1,8-octanediol-co-citric acid) films and 
scaffolds 
This chapter presents the results obtained after seeding myocytes in 
two and three-dimensional models. Scaffold morphology and surface chemistry 
modification as well as different seeding strategies were explored with the 
intention of setting the operational parameters for cardiomyocyte culture in a 
dynamic bioreactor. 
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4.1 Introduction 
4.1.1 Cardiomyocyte culture 
Cardiac cell lines are difficult to establish as they do not retain their 
electromechanical characteristics for long periods. Cardiac research has been 
based on the use of primary cells either from rat or mouse; however these cells 
are obtained after a difficult multi-step procedure. For the isolation of cardiac 
primary cells, a freshly removed heart must be perfused to remove all the 
blood and then digested before dissociating the ventricles to obtain a cell 
suspension. After purifying the cell suspension, the cells are ready to be plated 
and cultured [151]. Cardiac ECM is a complex network composed of structural 
proteins (collagen and elastin), adhesive proteins (laminin, fibronectin and type 
IV collagen), anti-adhesive proteins (tenascin, thrombospondin and 
osteopontin), proteoglycans, several growth factors and hormones. In addition 
to this, cardiomyocyte requirement for nutrients is elevated and they are highly 
susceptible to ischemia [152]. 
As alternatives to functional cardiac primary cells, smooth muscle and skeletal 
myoblast cell lines have been proposed as muscle models; C2c 12 and h9c2 
have generally been used lines for basic research. C2c 12 is a mouse skeletal 
muscle cell line that differentiates rapidly and forms myotubes. This cell line 
can be shifted from myoblastic to osteoblastic by supplementing the media 
with bone morphogenic protein 2 (BMP-2). H9c2 is a rat heart myoblastic cell 
line that also forms myotubes and has been reported as an in vitro cell line 
model to screen drugs [153]. It was not until ten years ago that a mouse 
cardiac muscle cell line, HL-l, was derived. This cell line can be serially 
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passaged and still preserve their morphology and physiology, including 
electromechanical coupling. HL-l cells have been used in several studies of 
cardiomyocyte physiology and metabolic activity [30, 154-159]. 
It is known that when culturing cells, different parameters may be needed to 
promote either proliferation or differentiation. Selective switching between 
proliferation and differentiation in cell populations is achieved by combining 
different culture media with biochemical factors and microstructures [160]. In 
the case of HL-l cells, it is recommended to incubate the culture surface with 
fibronectinlgelatine before plating the cells; additionally the media is 
supplemented with nor-epinephrine to retain their electrophysiological 
properties [30]. 
4.1.2 Cell adhesion 
Anchorage-dependent cells rely not only on physical substrates, such as glass 
or plastic, for attachment and differentiation, but mainly on proteins. Cell 
spreading, proliferation and repair pathways are influenced by this and by 
biochemical adhesion factors on the surface. Biochemical signals may result 
from the presence of peptides, proteins, carbohydrates and other molecules 
soluble in the cellular environment [151]. 
In order to mimic the biological processes during wound healing and tissue 
remodelling, tissue engineering considers the use of extracellular matrix 
(ECM) components as a key factor in tissue repair. ECM provides not only the 
structural support of cells but also the biochemical cues to moderate cell 
physiology and phenotype. Surface receptors in the cell recognise and translate 
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these signals into the indicated response. Cell adhesion regulates proliferation 
and differentiation and involves several receptors. Some receptors mediate 
adhesion to other cells (leading to assembly of 3D structures), and others 
adhesion to a physical surface to establish cellular orientation and spatial 
organisation. 
Cell adhesion onto a biomaterial can be either specific, with cell receptor 
recognition and binding to proteins or peptides, or non-specific, by non-
covalent attractive forces between cells and the biomaterial. Both improve cell 
adhesion and proliferation but in the case of non-specific adsorption, higher 
concentrations of coating are needed to achieve the same effect that in specific 
adhesion. 
Cell-to-cell adhesion regulates anchor (support cells), filtration and barriers, 
polarity, migration, metabolism, differentiation and proliferation. The main 
ECM molecules involved in this are collagen IV and laminin, although 
collagen XV, XVIII, and glycoproteins also intervene. 
Surface modification of a biomaterial to improve cell attachment 
Biomaterials should either include or promote ECM production with the aim to 
mimic cellular environment. By integrating a material with ECM components, 
cells are able to maintain a stronger interaction with the biomaterial and with 
adjacent cells. 
The first strategy is to biochemically modify material surfaces by adsorption of 
ECM proteins. A chemical approach involves ion-exchange reactions, 
dissolutions, and degradation to immobilise and attach compounds to surfaces. 
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Covalent coupling is also possible either by enzymatic attachment or during 
matrix formation. Bioactive surfaces incorporate proteins to elicit particular 
cell responses. Peptides are also used as these are recognisable sequences of 
ECM proteins such as RGD, present in fibronectin and YIGSR from laminin. 
Peptides do not exhibit differences in cell adhesion to that achieved with their 
native proteins; however it has been shown that they do not promote the same 
signalling for cellular physiology [161]. 
For cell to surface adhesion, ECM proteins are also used in addition to 
different compounds such as matrigel and serum, which contain adhesion 
factors such as fibronectin and vitronectin. Although most of them are well 
characterised, some compounds, such as serum have the disadvantage of being 
unreliable caused by its animal origin and the unpredictability of unknown 
components [162]. 
Collagen is the most common compound used to modify surfaces as it 
represents nearly one third of all proteins in the human body. Cardiac 
connective tissue is composed of fibronectin, laminin and elastin in addition to 
the collagen. Collagen is the major component of cardiac tissue, comprising 
85% of it and acting as the structural support for electro-mechanical 
contraction [163]. It has been observed that changes in the load affect the 
ECM, which changes in response to this. After myocardial injury, remodelling 
of the tissue starts with collagen fibre degradation followed by further 
development of type III collagen accumulation which prevents dilatation of the 
infarcted area. However when an excessive deposition of collagen occurs, 
collagen production leads to fibrosis, which accounts for stiffer muscle, 
arrhythmias and decreased cardiac function. This process is regulated by 
l38 
anti fibrotic factors such as Atrial Natriuretic Pepetide (ANP) and Brain 
Natriuretic Peptide (BNP) [164-166]. 
Besides the other main ECM proteins laminin and fibronectin, fibrin glues, 
hyaluronic acid and alginates are also used for clinical applications, including 
the coating of implants. Table 4-1 shows the three main ECM proteins, their 
location and their function. Coatings are also used to direct cell growth into 
specific patterns. Precise configurations are achieved by polymer lithography, 
photo-lithography, deposition or printing of concentration gradients. These 
differences in surface structure prompt distinctive responses at different times. 
These techniques also allow for specific cell distribution and mixed cultures 
[43]. 
Morphological modification of a biomaterial to improve cell attachment 
Scaffold morphology has been shown to affect cellular proliferation and 
differentiation. Porosity and pore size can induce different cellular responses 
with changes in morphology and phenotypic expression, fluctuating 
considerably with cell type and biomaterial. 
Scaffold porosity affects the availability of nutrients and oxygen. Higher 
porosity provide low resistance to mass transfer and therefore the supply of 
nutrients and waste exchange is less restricted than in scaffolds having a lower 
porosity. However, in the case where mechanical stability can be jeopardised 
by high porosity, it may be considered to compromise on a lower porosity to 
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type I Collagen Connective tissue, wound healing 
type II Collagen Cartilage 
type IV Collagen Basement membrane 
type VII Collagen Skin and Mucosa 
type VIII Collagen Endothelial, support endostatin formation 
type X Collagen Hypertrophic cartilage 
Plasma, connective tissue & basement 
membrane, binds cell surfaces and ECM. 
Fibronectin 
Control of migration, wound healing, 
proliferation and blood coagulation 
Basement membrane, regulate migration, 
Laminin 
embryonic development and neural system 
Table 4-1 Principal ECM proteins used in surface modification of biomaterials for cell 
adhesion 1161-163] 
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assure the mechanical stability of the construct. Van Tienen et al. reported that 
in scaffolds with low values of porosity and pore size, degradation began 
before the material was populated by the cells. However, they also reported 
that even in scaffolds with greater porosity and pore size, ingrowth was 
completed in the construct but the mechanical properties were also 
compromised by degradation [167]. 
Pore size affects cellular orientation and spatial organisation by facilitating cell 
to cell contact, metabolic activity, adhesion and migration into the structure. 
Although large pores may facilitate other processes, certain cells are not 
capable of bridging pores greater than their own diameter. Zeltinger et al 
evaluated the effect of porosity and pore size in fibroblasts, myocytes and 
epithelial cells and found that the minimal acceptable value to influence the 
cellular response in a positive way was a porosity of 90% and a pore size no 
greater than 38Jlm [168]. O'Brien et al. compared the cell adhesion of 3T3 
cells in collagen-glycosaminoglycan (CG) scaffolds having four different 
porosities, between 95 and 150 Jlm. They found that for these cells attachment 
decreased as the pore size increased [169]. According to the literature cell 
adhesion and proliferation is promoted by the size of the pores and by the type 
of porogen used to process the scaffolds when endothelial cells were used 
[170]. 
4.1.3 Seeding strategies for scaffolds 
The techniques used to seed cells into scaffolds can be classified into static and 
dynamic methods. Static seeding consists of either repipetting concentrated 
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cell suspensions into a three-dimensional scaffold or dripping the suspension 
and allowing it to passively infiltrate the matrices by gravity. 
Dynamic seeding includes dispersion by agitation, filtration, seeding on 
continuous/pulsatile perfusion chambers or seeding enhanced by vacuum, 
centrifugal or magnetic forces [43, 171-174]. Radisic et al compared two 
dynamic set-ups, an orbital shaker at 25 rpm and a perfusion cartridge at 0.5 
mUmin and found that cell viability and live cell yield decreased in dishes 
[175]. Shimizu et al reported high seeding efficiency of smooth muscle cells 
and fibroblasts into ex vivo scaffolds when using "Mag-seeding". This novel 
method labels cells with magnetic composites whilst a magnet is incorporated 
into the scaffold. The magnet-scaffold is then submerged in the labelled-cell 
suspension where cells are attracted to the scaffold. This procedure also allows 
the use of mixed population of cells in one scaffold [176]. 
Immobilisation and encapsulation of cells guarantee high concentration of cells 
in the scaffold but limit cell migration and mass transfer, leading to cell death 
in the core of the structure [173]. Seeding efficiencies of static and dynamic 
methods vary depending on the cell type and biomaterial architecture. 
4.1.4 Aims 
The aim of this chapter was to optimise myocyte culture for three-dimensional 
myocyte culture in POC scaffolds using 2D POC film models. The first 
objective was to assess the effect of modifications in the biomaterial surface 
and architecture. The hypothesis was that the adsorption of cardiac ECM 
proteins to the POC surface would improve cell adhesion and survival. In 
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addition to this it was expected that higher porosities should promote increased 
survival when compared to lower porosities. 
The second objective was to analyse different seeding techniques to determine 
the most favourable seeding conditions. The hypothesis was that dynamic 
seeding would promote a more homogeneous cell distribution and attachment 
whilst static seeding would confine cells to limited areas, influencing viability 
and phenotype as a consequence. Dynamic seeding techniques result in 
constructs with increased cellular density and ECM production when 
compared to static strategies [167]. Nevertheless dynamic seeding could also 
impair cell adhesion for some cells and so it was relevant for the project to 
evaluate the effect of high agitation rates for these cells and this material. 
4.2 Materials and methods 
4.2.1 Manufacture of POC films 
The POC films were manufactured as in section 2.4. Briefly 109 of 
powdered citric acid was added to 7.61 g of powder 1,8-octanediol and melted 
at high temperature. POC pre-polymer solution (POC in acetone) was then 
placed in PTFE moulds to cure at 80°C for two weeks. 
4.2.2 Casting of POC scaffolds 
POC scaffolds were processed as previously described in Section 2.1.2.2. POC 
pre-polymer solution was dissolved in acetone at 33.3% (w/v) before being add 
to a PTFE mould containing sodium chloride. The mixture was allowed to 
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polymerise for two weeks and was then washed in distilled water to remove 
the porogen particles. 
4.2.3 Cell culture 
HL-I cardiomyocytes were obtained from Dr. Claycomb «Louisiana State 
University - Health Sciences Center, USA) and cultured as described in 
Section 2.2.1. HL-I cells used in the studies discussed in this chapter were 
between passages 61-75. C2cl2 myocytes were obtained from the ECCAC 
and cultured as detailed in Section 2.2.2. C2c12 cells used for seeding 
experiments were between passages 40-58. 
4.2.4 Seeding cells into scaffolds 
Scaffolds were prepared for cell culture as described in section 2.2.3. 
Scaffolds were conditioned for cell culture and sterilised before being seeded 
either with HL-I cells or with c2cl2 cells as described in section 2.2.5. 
Briefly, cells were trypsinised and re-suspended in cell culture medium to a 
concentration of 3.2 x IOs cells per mL. For static and dynamic seeding 
techniques, 250 JlL of the cell suspension was pipetted through each scaffold 
in a 6-well non-tissue culture treated plate and allowed to incubate for 30 
minutes before adding 5 mL of media. Static seeded constructs were incubated 
for 24 hours before analysing cell survival. Dynamic seeded constructs were 
immediately agitated in an orbital shaker at 100, 200 and 300 rpm for 24 hours. 
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Scaffolds were seeded in triplicate for cell viability assays and image analysis 
and were assessed after 24 hours. 
Centrifugation seeding was achieved by placing a conditioned scaffold in a 15 
mL Falcon tube containing 5 mL of a 16 x 103 cells/mL cell suspension. The 
tube was centrifuged at 7000 rpm (13,000 x g) for 7 minutes. Supematant was 
discarded and the resultant construct was incubated at 37°C for 24 hours before 
being analysed for cell survival. 
4.2.5 Surface modification 
The POC film surface was modified as described in Section 2.3.2. Protein 
suspensions were prepared for fibronectin, collagen and laminin at their 
optimum concentration for myocyte culture and then serially diluted to assess 
the effect of the concentration on cell survival. 
4.2.6 Analysis of cell viability 
Relative cellular viability was assessed by the Alamar blue assay as described 
in Section 2.4.1. Briefly, the constructs were transferred to a 24-well plate and 
washed three times with PBS. Samples were incubated with 1 mL Alamar blue 
working solution for 90 minutes at 37°C. Samples were shaken for 15 minutes 
and then analysed in a fluorescence plate reader at excitation and emission 
wavelengths of 530 nm and 590 nm respectively. The number of cells was 
calculate using the calibration curve for the cells. 
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Scaffolds conditioned for cell culture but not seeded were used as controls; 
these were also incubated and analysed for Alamar blue after 24 hours. 
4.2.7 Inverted microscopy and total area 
Images of c2c 12 and HL-l monolayer culture were taken as described in 
section 2.5.1. Briefly random images were taken at high magnification (20x) 
and then analysed for area coverage using Leica QWin software associated 
with the microscope. 
4.2.8 Imaging of cells on scaffolds 
POC scaffolds and constructs were analysed by light microscopy and SEM as 
described in Sections 2.5.4 and 2.5.5. In brief, samples were fixed and stored at 
4°C. Before processing samples in osmium tetroxide they were washed and 
dehydrated. After treatment specimens were sputter-coated in gold before 
using a field emission scanning electron microscope Jeol. 
4.2.9 Statistical analysis 
Data was analysed for mean values and standard deviation using Microsoft 
Excel 2002 as described in Section 2.6. 
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4.3 Results and Discussion 
4.3.1 Monolayer culture of c2cl2 and HL-l cells 
The c2c12 line is a mouse myoblast cell line widely used for myogenesis 
research. These cells proliferate rapidly and provide a model for studies 
involving a large numbers of cells such as the seeding experiment. HL-l is a 
cardiomyocyte cell line which takes longer to proliferate, however this is the 
only cardiac cell line characterised for cellular biology. It was considered to 
assess both, a myoblast cell line and a cardiomyocyte cell line to investigate 
the compatibility of muscle cells to the flexible biomaterial. Although the 
target application was cardiac tissue engineering, it was considered that 
evaluating the material with another muscle line could provide valuable 
information. C2c 12 cells were also thought as a surrogate cells for experiments 
that require large amount of cells in the case that HL-l cells did not reach the 
quantity required. C2c 12 cells and HL-l cells inspected visually with an 
inverted microscope did not display conspicuous morphological changes when 
cultured as mono layers on tissue culture plastic (TCP) flasks. Moreover both 
cell lines behaved as expected and exhibited elongated phenotype as can be 
seen in Figure 4-1. C2c12s organised more rapidly into myofibres than HL-l s. 
However, HL-l cells exhibited contraction when confluence was greater than 
70%; normal contraction ratios were observed with some areas of synchronic 
beating when confluence was higher than 80%. Myocytes were seeded on POC 
films to assess the biocompatibility of the material with these cells. SEM 
images of monolayer culture of c2c12 cells on POC were analysed for cell 
coverage, showing poor attachment to the surface of uncoated films when 
compared to area coverage in untreated TCP (Figure 4.1A and 8). HL-l cells 
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Figure 4-1 Images of c2c12 myocytes cultured on untreated (A) TCP and (B) POC mm and HL-1 cardiomyocyte monolayer cultures on CC) untreated TCP, CD) 
untreated POC, (E) treated TCP and CF) treated POC. TCP images are on day 3 while in POC are on day 1. 
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displayed the same attachment levels in POC as in TCP flasks, minimal 
adhesion on untreated surfaces whilst good attachment on treated materials 
(Figure 4-1 C - F). This difference in cell attachment was caused by the surface 
modification which was pre-coated with gelatine/fibronectin for HL-l s as 
previously recommended by the supplier. 
4.3.2 3D culture of c2c12 and HL-l in POC scaffolds 
At the same time C2c12 and HL-l cells were cultured in POC scaffolds in 
three-dimensional structures. Figure 4.2 shows scanning electron micrographs 
for both cell lines with minimal adhesion. Myotube fonnation did not occur 
when the cells were seeded on POC scaffolds and allowed to incubate for 24 
hours. SEM revealed no real presence of cells in the scaffold. Low levels of 
cell adhesion were thought to be caused by a low affinity of the cell surface 
receptors to poe ligands, the absence of anchoring proteins and the presence 
of acidic monomers. These two factors were further investigated in subsequent 
studies to improve cell attachment and proliferation before conducting long 
tenn culture studies. 
4.3.3 Surface coating with Extracellular Matrix (ECM) Proteins 
Surface modification was used to improve cell attachment on poe scaffolds. 
POC scaffolds were coated by adsorption with three ECM proteins: 
fibronectin, collagen and laminin, to assess the effect on cell adhesion. 
Different concentrations were used starting with the optimum reported for 
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Figure 4-2 Images at low and high magnification or (A-B) c2c12 cells and (C-D) HL-l cells cultured on un-conditioned POC scaffolds for 24 hours. Poor attachment 
is caused by the low affinity of the cell surface receptors to POC ligands, absence of proteins on the surface and acidic conditions. Arrows show dead cells. 
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Fibronectin Collagen Laminin 
Figure 4·3Representative images of area coverage of HL·l cells after 18 hours cultured 
on poly(I,8-octanediol·co·citric acid) [PO C) films coated with proteins at different 
concentrations: Fibronectin (A) 400 ~ c m 2 , , (8) 40 ~ c m 2 , , (C) 4 ~ c m 2 2 and (D)control· 
PBS; Collagen (E) 10 J.Lg/cm2, (F) 1 J.Lg/cm2, (G) 0.1 J1g/cm2, and (H) control.PBS; Laminin 
(I) 2 J.Lg/cm2, (J) 0.2 ~ c m 2 " " (K) 0.02 ~ c m 2 2 and (L)control·PBS. 
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concentrations [J1g/cm2] as indicated (n=3, mean + SD, *** indicates p < 0.001). 
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myocytes and then diluted 1:10 and 1:100 as detailed in Section 2.3.2. After 18 
hours of incubation on the surfaces, HL-l cells were imaged. 
Figure 4-3 shows images of area coverage per protein per concentration. These 
data were analysed and is summarised in Figure 4-4. The graph shows that 
cells seeded on POC films coated with fibronectin covered a larger area than 
those seeded on collagen and laminin coated films. This result is consistent 
with the high seeding efficiency reported by Boublik et al when fibronectin 
was used in their cardiac constructs [150]. Alternative coatings to the 
suggested by the supplier of HL-l cells were considered as collagen is an 
important part of the cardiac ECM, representing more than 85% of the cardiac 
ECM. On the other hand, laminin is recommended as a coating for primary 
cardiac cells in most of the isolation and culture protocols available. Previous 
studies have also shown that ECM proteins influence cardiac cell morphology, 
motility, gene expression, survival of adherent cells and physiology. Lungdren 
et al found that after two weeks of culture, myocytes seeded on dishes coated 
with collagen and laminin formed a denser monolayer than those cultured on 
uncoated plastic dishes, and also exhibited spontaneous contraction [178]. 
Fibronectin used at a concentration of 400 IJ-glcm2 showed a 90% ± 5% HL-l 
cell area coverage in contrast to 32% ± 4% with the same protein coated at 40 
J..lglcm2 and to 11 % ± 1 % when the concentration of the fibronectin was the 
lowest (4 J..lglcm2). It can be alleged that initial concentrations are not the same 
for the three proteins in this study; however the concentrations used are the 
optimal values for each ECM protein according to the existing information. 
Cell coverage on collagen and laminin coated films showed inferior area 
coverage when compared to fibronectin coated materials. The cell coverage for 
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laminin was only comparable to that of the PBS controls. In these studies, cell 
coverage also decreased as the protein concentration reduced, reaching the 
same levels of attachment as uncoated films with the lowest concentrations. 
Results indicated that fibronectin was the best of these three ECM protein 
because not only enhanced myocyte adhesion to the POC film but most 
importantly maintained the cell morphology. This could possibly be related to 
the fact that a higher level of fibronectin expression is associated with cell 
proliferation and migration at the embryonic stage of heart development whilst 
during heart growth, fibronectin levels decrease and laminin and collagen 
levels increase. Also in contrast to smooth muscle cells, cardiomyocytes are 
not capable of fibronectin synthesis but only of type IV collagen and laminin 
synthesis [152]. An increased attachment ratio with fibronectin is also 
explained by fibronectin being recognised by ten different binding receptor 
integrins [179]. This supports the finding that a fibronectin coating was 
advantageous for obtaining high area coverage of cells and expressing the 
cardiac phenotype, and therefore this protein was used to coat the POC 
scaffolds for the remaining cellular studies. 
4.3.4 Analysis of the effect of different porosities on the proliferation of 
HL-ls 
Following surface modification studies, porosity of the POC scaffolds was 
examined as another factor for cell attachment and survival. HL-l cells were 
seeded statically in these scaffolds to assess how the porosity affected cell 
survival. As previously discussed a minimal value of porosity is needed for 
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cells to proliferate and differentiate. Highly porous structures are thought to 
promote cell phenotype and physiology and to support migration, which is 
desired for tissue engineering ingrowth in the scaffold [180]. 
Cell number analysis as determined by alamar blue after 24 hours revealed no 
significant differences between cell proliferation for the three different 
porosities (Figure 4-5). Table 4-1 illustrates a minor trend of increasing cell 
concentration in more porous scaffolds; however considering the standard 
variation for these analyses, the differences are not significant with p values 
greater than 0.05 when comparing results of 60% and 80% porous and p 
greater than 0.19 in the other cases. Furthermore, Figure 4-6 presents 
fluorescent images of live cells where the same phenotype and adhesion levels 
were observed for the three different porosities. This study established little 
change in HL-l survival on poe scaffolds whether the porosity varied 
between 60% and 80% and therefore this was not a factor to consider when 
deciding the best scaffold to culture HL-l cells on. The changes in the 
mechanical properties dependant upon porosity were more relevant for this 
project. It was hence decided to use 70% porous as these poe scaffolds 
satisfied the requirements of a highly porous structure with mechanical 
integrity. The mechanical properties of 80% porous constructs were much 
more compromised than those 60% and 70% porous. 
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POROSITY RLL.\TI\"!' SIR\W.\I. (± STD) [ :\ 10; CEI.I.S] 
60 % 125 ± 12 % 
70 % 131 ± 10% 
80% 137± 10 % 
Table 4·2 Relative survival of HL·1 cells after 24 hours of culture in POC scaffolds of different porosities analysed with Alamar Blue 
Figure 4·6 Fluorescent images of HL·1 cells stained with LivelDead after 24 hours of culture in (A) 60%, (B) 70% and (C) 80 % POC scaffolds 
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4.3.5 3D culture - Static vs. dynamic seeding 
After establishing the use of 70% porous scaffolds and fibronectin coating for 
further cellular studies, seeding conditions in 3D scaffolds were assessed to 
determine if seeding efficiency could be improved. 
C2c 12 myoblasts and HL-l cardiomyocytes were seeded under static and 
dynamic techniques as described previously in Section 2.23. HL-l cells were 
seeded on POC scaffolds by static, centrifugal and agitated seeding at 100, 200 
and 300 rpm; whilst C2c 12 cells were only assessed for static and dynamic 
seeding at 100 rpm due to a cell availability limitation. Cells were incubated 
using the experimental conditions for 24 hours before evaluating cell number 
and morphology of the cells on the scaffold. 
SEM allowed visualisation of HL-I and c2c 12 cells after 24 hours of culture 
on POC scaffolds (Figures 4-7 and 4-8). Transversal imaging of the constructs 
was not possible because of the thinness of the scaffolds (2 mm); hence 
internal distribution could not be confirmed. Representative images of HL-l 
cells seeded by centrifugation demonstrated low attachment and survival; 
however the few cells that adhered to POC, presented the typical phenotype. 
Normal cell morphology was thought to be as a result of the static incubation 
after the centrifugation seeding step. Although centrifugation concentrates the 
cells available in the cell suspension in a certain volume, seeding HL-l cells by 
this method did not increase the number of cells within the scaffold. This was 
explained as a technical issue resulting from the morphology of the scaffold 
complicating the homogeneous deposition of cells throughout the whole 
structure. Godbey et af overcame this by designing a special rotor to centrifuge 
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Figure 4-7 Images of HL-I ceUs after 24 hours of culture in POC 70% scaffolds coated witb fibronectin at 400 JJg/cm2seeded by (A-C) centrifugation, (D-F) static, 
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static dynamic (100 rpm) 
Figure 4-8 Images of c2c12 cells after 24 hours of culture when seeded on 70 % POC film 
scaffolds coated with fibronectin at 400 ~ c m 2 2 seeded by (A-C) static method and by (D-
F) 100 rpm dynamic seeding. 
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cylindrical constructs to ensure that the axis of rotation ran through the central 
lumen of the scaffolds. It was found that seeding efficiency, time and 
distribution were superior in centrifuged constructs compared to static and 
spinner flask [173]. 
Cells seeded statically showed not only a high ratio of attachment and normal 
phenotype but also greater viability, 162%, when compared to those seeded at 
100 rpm after 24 hours (Figure 4.9). Dynamic seeding at this low agitation 
ratio presented acceptable viability (112%) but cells were smaller when 
compared to fully differentiated cardiomyocytes. When specimens were 
analysed by fluorescent stereo-microscopy, those seeded by centrifugation at 
200 and 300 rpm showed no sign of the presence of live cells. In contrast, POC 
scaffolds seeded with HL-I cells either statically or at 100 rpm, displayed live 
cells not only in the surface but also inside pores, as can be seen in Figure 
4.10. It was impossible to image dead cells (stained red) due to partial auto-
fluorescence of the POe. 
Increasing the seeding speed to 200 and 300 rpm led to minimal cell 
attachment after 24 hours. The effect of agitation speed was negative in cell 
adhesion for speeds greater than 100 rpm as cells did not exhibit cardiac 
phenotype when seeded with these treatments. Differences in cell density, 
DNA content and metabolic activity between dynamic seeding techniques can 
also be caused by the vessel configuration. Carrier et al compared seeding 
neonatal rat cardiomyocytes in a rotating vessel and in mixed flasks. This 
group reported that cell damage in dynamic seeding was mainly due to 
turbulent flow in contrast to laminar flow which reduces cell damage [79]. 
Xiao et al reported that the combination of a dynamic technique for seeding 
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0.001). 
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Figure 4-10 Fluorescent images of 70% POC film scaffolds seeded with (A) c2c12 cells by static seeding, (B) c2c12 cells seeded at 100 rpm, (C) HL-t cardiomyocytes 
statically and (D) HL-l cardiomyocytes seeded dynamically at 100 rpm. Samples imaged after 24 hours using UV microscopy after LivelDead staining. 
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following by static incubation of constructs was more beneficial for the cells 
than only dynamic or static methods [177]. Burg et at also experimented with 
different seeding/incubation methods and found that a dynamic seeding 
followed by bioreactor incubation for a week proved to increase metabolic 
activity and cellular infiltration. However, static methods were not the most 
inferior method [181]. In this study SEM demonstrated that the survival and 
differentiation of cardiomyocytes within these POC scaffolds were highly 
affected by agitation speed. Static seeding appeared to be the most favourable 
condition to seed HL-l s in 70% porous POC scaffolds. 
C2c12 cells were imaged by SEM as shown in Figure 4-8. Constructs seeded 
either static ally or at 100 rpm contained high number of cells, 225% vs. 137% 
survival respectively. Static seeding was also confirmed to be more 
advantageous condition for seeding c2c12s in POC scaffolds based on a 
superior viability. This was also confirmed by fluorescent live/dead staining as 
shown in Figure 4-10. 
Radisic et al indicated that perfusion is the only seeding method that provides 
oxygen during the seeding, maintaining viability, high cell density and uniform 
distribution [182]. However the use of this seeding technique is restricted by 
the construct architecture and by the compatibility of the perfusion system with 
the bioreactor for long-term culture. 
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4.4 Conclusions 
Scaffold surface and architecture as well as seeding strategy are fundamental 
factors when working with 3D models. Before introducing another variable, 
mechanical stimulation, it was crucial to establish the best possible seeding and 
culture conditions specific to the cell lines and the biomaterial. 
The results presented in this chapter sought to compare several conditions to 
improve cell adhesion of myocytes in a novel flexible biomaterial. It was 
confirmed that myocytes require certain biochemical properties on the surface 
to adhere to POC. The surface modification study proved that fibronectin was 
a more advantageous coating compared to collagen and laminin. For each 
protein, a clear trend of decreased attachment was found when the protein 
concentration decreased on the surface. 
Changes in the architecture of the scaffold showed little impact on cell survival 
at porosities between 60% and 80%, making the mechanical properties of the 
construct the fundamental factor to decide the most suitable porosity to be used 
in the following studies. 
After testing static and dynamic seeding strategies, it was found that POC, 
being a highly hydrophilic material, enhances cell attachment and supports a 
better cell survival and differentiation when static conditions are applied. It 
was also concluded that the optimum seeding conditions did not vary between 
c2c12 and HL-I cell types. 
These optimisation studies led to the parameters established for the work in the 
mechanical bioreactor as presented in the next chapter. 
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5 Comparison of culture of cardiomyocyte constructs 
on a mechanical stimulated bioreactor and static 
culture 
This chapter is mainly concerned with the effect of mechanical 
stimulation on cardiomyocytes. Cardiac constructs are cultured in Tencell, a 
dynamic bioreactor, and assessed for morphology, survival and gene 
expression. 
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5.1 Introduction 
5.1.1 Mechanical stimuli in cardiomyocytes 
Mechanical forces play a significant role on muscle organogenesis and growth 
by modulating cellular proliferation, metabolic activity, ECM composition, 
gene regulation and protein expression and organisation. Cardiomyocytes are 
terminally differentiated cells that respond to excessive workload only by 
hypertrophy (an increase in cell size) and not by hyperplasia (increase in cell 
number) [183]. After increased cardiac load, cells adapt to the new conditions 
by modifying the gene program into hypertrophy and increasing contractile 
strength and peptide secretions [184-189]. Mechanical stimulation of in vitro 
myocytes has shown similar effects on cellular morphology and physiology 
when compared to in vivo cells subject to a mechanical force [179-183]. 
Vandenburgh et al reported that statically stretched skeletal myocytes showed 
increased levels of aminoacids, total proteins and particularly of myosin heavy 
chain (MHC) protein [190,193]. Reports of the effect of mechanical 
stimulation on cardiomyocytes are limited, mainly with information limited to 
cardiac loading also effect on myocyte by modifying fibre orientation and 
length leading to contraction rate/force changes [194]. Cardiomyocytes and 
cell types such as smooth muscle cells and endothelial cells, change their 
orientation in response to mechanical stimulation usually aligning on the 
direction of the stretching force [195-198]. Stretch regimes are also important 
for reaction and alignment in mammalian cells, Vandenburgh and Karlish also 
found that the cellular response of stretched cells in a slow uni-axial stretch 
affected fibre orientation and length in mammalian myocytes [199-200]. 
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5.1.2 Cardiac gene markers 
Molecular markers have been used to monitor changes in genetic expression 
levels and signalling pathways for transcriptional activation. One of the 
cellular responses after cardiac injury or overload is the reactivation of a 
program of immediate early gene expression; this up-regulates embryonic 
genes encoding for ANP, BNP, ~ - M H C C and x-skeletal actin [201-204]. The 
cardiac genes induced in response to cardiac load are classified by the response 
time. Immediate early genes which respond within one hour include BNP, c-
fos, c-jun and c-myc. Intermediate response genes, responding after several 
hours, include ANP, ~ - M H C , , skeletal a-actin and Collagen III whereas late 
response genes, which show a response after days, are Collagen I and cardiac 
a-actin [205-212]. 
ANF 
Atrial natriuretic factor or peptide (ANF or ANP) is a hormone secreted by the 
heart and encoded by the gene nppa. This peptide is triggered by 
hemodynamic stress and regulates vasodilatation (blood pressure), diuresis and 
natriuresis [203, 213-215]. This hormone belongs to the family of natriuretic 
peptides and is present in important levels during embryogenesis and cardiac 
hypertrophy [216]. ANP importance has been highlighted by knockout models 
which showed that alterations in this gene cause hypertension [217-219]. It has 
also been reported that genetic variations are a factor in cardiac remodelling 
and hypertrophy; increased levels of ANP are considered a prognostic 
168 
indicator in cardiac failure [220-221]. King and Wilkins suggested that ANP 
also plays a role in the protection of the myocardium by inhibiting cardiac 
fibrosis and myocyte hypertrophy; as it was shown that ANP inhibits collagen 
production and induces apoptosis [222]. Ruskoaho et al demonstrated that 
after overload the level of ANP mRNA is increased and that myosin heavy 
chain and skeletal alpha actin are equally increased although cardiac alpha 
actin mRNA decreased [223]. 
Cardiac actin gene (actc) 
The actin isoforms ~ - S k e l e t a l l and cardiac are two of the twenty actin genes 
present in the human genome. :.t-Skeletal actin is expressed after myoblast 
differentiation and is prevalent in the embryonic heart but down-regulated after 
birth. The actc gene encodes for cardiac actin, the sarcomere thin filament 
protein that regulates muscle contraction. Mutations in this gene have been 
shown to cause cardiomyopathies [224]. Previously, Black and Packer reported 
the use of smooth muscle alpha actin, correlated with skeletal alpha actin, as a 
molecular marker of pressure-overload hypertrophy [225]. 
Myosin heavy chain genes (myh) 
Myosin is a cardiac protein present in the sarcomere thick filament. The first 
isoforms, ~ M H C C is characteristic of embryonic and adult heart and is 
expressed in newly formed cardiomyocytes. Mutations in this gene can lead to 
enlargement of the left ventricle [226]. 
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5.1.3 Dynamic Bioreactors 
Bioreactors provide a culture environment conducive to cell aggregation and 
supply an instrument for study of tissue formation and cell physiology under 
variable biological and biochemical conditions (Table 5-1). Mechanical 
stimulation has been studied in culture systems that control the mechanical 
load applied in vitro. The first bio-mechanically active bioreactors for cell 
culture were perfusion and membrane bioreactors that induced shear stress but 
neither tensile nor compressive load. The first approach for more complex 
mechanical bioreactors was to design laboratory-scale bioreactors. However in 
the last decades, mechanical stimulated bioreactors have been manufactured to 
meet the researchers' needs and its market has grown due to more research 
groups involved in regenerative medicine. Current commercial models are 
limited and expensive and therefore there is still a need for some groups to 
design their own. 
Dynamic bioreactors can be classified mainly in those that apply compression, 
tension or fluid shear stress. Compressive systems are commonly used for 
bone, cartilage or endothelial applications as these cells stand this load in vivo. 
Shear stress has been used to evaluate its influence on protein expression, ion 
channels and cytoskeletal remodelling [227]. Tensile systems have been 
developed to stretch lung, bone, ocular, muscular and vascular cells. This uni-
axial load has been applied by diverse actuators such as solenoids, 
electromagnets, pneumatic pistons and even by manual screws [228]. The 
following bioreactors are available for mechanical stretching stimulation 
(Figures 5-1 and 5-2). 
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('O-LO( ',HIO' 01-' 
SmTI{ STRESS :\l\ss TR\:\SI-'ER DI ,\lnsIO' ,\Un CELL DE'Sln 
DISSI\IIL\I{ CELL T, PES 
Static Culture System (T -Flasks) None Adequate 20 3-4 layers 20 Limited 0.3-1xI06 cells/ml 
Static Matrix Cultures None Limited 3D Limited 3D Limited Low 
Roller Bottles Medium Good 2D 3-4 layers 2D Very Limited 1-5x I 06 cells/ml 
Stirred Suspension Culture Medium/High Good Very Limited 3D Very Limited 106_107 cells/ml 
Airlift Bioreactors Medium/Low Good Very Limited 3D Very Limited 106_108 cells/ml 
Hollow Fibre Perfused Systems None Good Limited 3D Limited 107_108 cells/ml 
ITEMS Medium Excellent Excellent 3 D Excellent N/A 
Dynagen Medium Excellent Excellent 3 D Excellent N/A 
Flexcell Medium Limited 2D Limited 2D Good N/A 
Tencell Low Limited 3D Good N/A 
Table 5-1 Characteristics of different bioreactors for cell culture 12431 
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Figure 5-1 Commercial dynamic bioreactors (A) BioDynamics by Bose/Enduratec, (8) FlexceU, (C) RCCS, and (D) DynaGens by TGT [232-236] 
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Figure 5-2 Digital images of custom-made multi-station dynamic bioreactors: (A) 
Miniature Load and Strain-Controlling Bioreactor (Northeastern University, USA), (B) 
Bioreactor for controlled stretch and flexure of soft biological materials under cell-
culture conditions (University of Pittsburgh, USA) and (C) Tencell (Leeds University, 
UK) [92, 229, 230]. 
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Custom-built Bioreactors 
Researchers require specific bioreactors that were not available up till now. 
This problem and the high cost of commercial systems made tissue engineers 
work together with engineers to design and build bioreactors that apply the 
forces researchers need. 
A miniature load and strain controlling bioreactor was designed and built by 
researchers of Northeastern University in Boston, USA, to analyse the 
mechanics of tissue when a tensile load is applied. This bioreactor was 
developed to study the mechanical properties, deformation and growth of 
collagen in tissues [229]. Another research group from Pittsburgh University 
has designed several mechanical bioreactors, including a bioreactor for 
controlled stretch and flexure of soft biological materials under cell-culture 
conditions. This system was designed to study the effect of dynamic 
stimulation in tissue engineered heart valves. This bioreactor applies uni- and 
bi-directional cyclic flexure to specimens arranged in 6-wells plates contained 
in chambers. The frequency, amplitude, acceleration, and deceleration profiles 
are controlled by the software operating the bioreactor [230]. 
Tencell is a dynamic bioreactor that applies controlled cyclic tensile strain to 
constructs in a controlled setting. Leeds University researchers designed 
Tencell to culture cell-seeded collagen gels and tissue equivalents in order to 
study the biological response of biomaterials in a functional environment. This 
bioreactor contains 16 individual chambers in a sealed vessel, 8 of which are 
coupled to a uni-axial mechanical actuator that can be set up either to apply 
tension or compression loads. Tencell has previously been used to study 
orthopaedic implants, skin models and tissue engineered aortic heart valves 
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[92]. Zhonggang et al has also reported the design, fabrication and 
performance of an electro-tensile bioreactor. This system was developed to 
simulate the electrical and mechanical stimuli in cardiomyocyte-seeded 
collagen gels and other cardiovascular constructs [231]. 
Rotary Cell Culture System (RCCS) (Synthecon Incorporated) 
The Rotary Cell Culture System is a bioreactor developed by the National 
Aeronautics and Space Administration (NASA, USA) which enables the study 
of three-dimensional cultures under micro gravity conditions. The system was 
initially designed to protect tissue samples during space flight but because of 
the unique micro gravity environment it was exploited as a bioreactor. The 
RCCS integrates a culture system with high mass transfer of nutrients, 
metabolic products and gases in addition to providing a low shear 
environment. Inside the vessel, the particles are suspended by rotation as its 
centrifugal force equalises the gravity force preventing sedimentation. Cells 
can be cultured in suspension or in constructs up to several months. This 
bioreactor is commercialised by several companies and used for research such 
as tissue regeneration, cancer research, in vitro toxicology and production of 
monoclonal antibodies, proteins and pharmaceuticals [232-233]. 
Flexcell 
Flexcell is a "computer-regulated" pneumatic bioreactor which enables the 
creation of three-dimensional cultures under strain conditions. This system 
provides strain by applying vacuum pressure to the cells seeded on special 6-
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well flexible plates. Static and cyclic strain or compression can be applied to 
monolayer cultures in different frequency and amplitude regimens. Flexcell 
supports the creation of three-dimensional cell-seeded gels [234]. 
Intelligent Tissue Engineering via Mechanical Stimulation (ITEMS) 
Bioreactor 
The ITEMS Bioreactor is an EnduraTEC I Electroforce (Bose) system that 
provides a biodynamic environment for three-dimensional constructs. This 
bioreactor is able to apply mechanical stresses and strains to constructs 
contained in the "closed-loop nutrient-flow subsystem". The ITEMS is 
controlled by software that also allows the user to perform real time 
mechanical analysis. In addition to this, pressure and flow frequency and 
regimen can be varied. ITEMS can be arranged for one module or multi-station 
with 6 chambers, each of which can be loaded with axial and/or shear stress 
[235]. 
DynaGen® 
The DynaGen bioreactor, by Tissue Growth Technologies, is the generic name 
for the series of bioreactors that are customised for diverse tissue engineering 
applications, including bone, cartilage, vascular and ligament. The DynaGen 
provides a mechanical stimulated 3D culture environment. These bioreactors 
apply tension and compression through mechanical pulsatile pressure 
combined with low and high flow rates. The system is fully integrated to a 
computer for the control of flow and load configurations [236]. 
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5.1.4 Aims 
The aim of this chapter was to assess the effect of culturing HL-I 
cardiomyocyte on 70% porous POC scaffolds under dynamic conditions in the 
Tencell bioreactor. The first objective was to evaluate the seeding and culture 
conditions to then incubate the constructs for one week under continuous and 
discontinuous stretching regimes. The evaluation of this dynamic culture was 
to be done by comparing the relative expression of cardiac genes, survival, 
morphology and distribution of cardiomyocytes in the 70% porous POC 
scaffolds. 
5.2 Materials and methods 
5.2.1 Preparation of Scaffolds 
Scaffolds were manufactured and prepared for cell-seeding as explained in 
Sections 2.1.2.b, 2.3.1 and 2.3.2. Scaffold surface modification was carried out 
using fibronectin according to the results of Section 4.3.3. 
5.2.2 Cell culture 
HL-ls, obtained from Dr. Claycomb, were cultured as described in Section 
2.2.1. 
5.2.3 Culture of cell-seeded scaffolds 
For the initial seeding study, scaffolds were statically seeded with HL-l cells 
as outlined in Section 2.3.4 at a density of 0.55 x l06 and 1.1 x 106 cells per 
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mL per scaffold and then transferred to the Tencell bioreactor for static 
incubation for 20 hours at 37°C and 5% C02. 
For the mechanical stimulated study, cells were seeded directly in the Tencel1 
at 0.55 x 106 cells per mL per scaffold and incubated for 60 hours before 
starting the stretching regimen according to Section 2.3.6. Constructs were 
either stimulated continuously or discontinuously 4 hours per day. All cultures 
were maintained for I week in the stretching regimen. 
5.2.4 Analysis of constructs 
Following one week of mechanical stimulated culture, constructs were 
removed from the bioreactor and washed in PBS. From the eight constructs in 
each condition, three were placed in RNAlater buffer for further qRT-PCR 
analysis. Alamar blue assay was performed in three other constructs and then 
washed in PBS to be prepared for SEM imaging. LivelDead assay was carried 
out in the last two constructs, one of which was also immunostained for actin. 
Alamarblue 
Alamar blue assay was performed to assess the cell survival for each scaffold 
according to Section 2.4.1. The number of cells was calculated using the 
calibration curve for the HL-l s. 
Quantitative RT -peR 
Samples were preserved III RNAlater at -20° before being analysed as 
described in Section 2.4.2. 
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Immunofluorescence staining of sarcomeric actin 
One sample was cut in two halves to be stained for LivelDead and for 
sarcomeric actin. The immunofluorescence was carried out as previously 
described in Section 2.5.2 to confirm the presence of the protein 
LivelDead assay and Confocal microscopy 
Constructs were washed and incubated for LivelDead Assay before being 
imaged in a Stereo and a confocal microscope as detailed in Section 2.5.3. 
SEM 
Constructs were fixed in glutaraldehyde before SEM processing and imaging 
as described in Section 2.5.4. 
Statistical analysis 
The statistical significance of these results was evaluated usmg Microsoft 
Excel 2002 (Microsoft Corporation 2002, USA). Results are expressed as 
mean ± standard deviation (SD) when available. Data was analysed on 
triplicates unless otherwise stated in the analysis. T -tests of two samples 
assuming equal variances were performed as described in Section 2.6 to 
compare culturing conditions results. 
179 
5.3 Results and Discussion 
5.3.1 Differences in seeding concentration and in situ incubation 
The first approach for these studies was to seed HL-1 cells onto the scaffold 
and then transferring the seeded constructs into the Tencell bioreactor. It was 
hypothesised that seeding directly into the Tencell could have an effect in 
seeding efficiency. It was also speculated that the initial seeding concentration 
could affect cell survival. poe scaffolds were prepared for cell culture and 
then HL-1s were seeded in poe scaffolds at 55 x 103 and 110 x 103 cells per 
scaffold and incubated for 20 hours either in a Tep plate or seeded directly 
into the Tencell chambers. poe scaffolds were cut into the chamber 
dimensions and prepared for cell culture. Figure 5-3 shows the scaffold before 
the conditioning process and after the cells were seeded into the Tencell and 
cultured in it. Because of the geometry of the bioreactor, HL-1 s concentrated 
in the central part of the scaffold between the clamps. Clamped areas were 
marked by a darker zone because of the reaction of the materials; this was 
attributed to a reaction of the metal to the elastomer. This has been observed 
with all other biomaterials used in the Tencell without affecting proliferation or 
survival [237]. 
Visually there was a difference between seeding in plates or in the Tencell 
(Figure 5-4 and 5-5). When seeding at low initial cell concentration, mean 
survival of cells in constructs incubated in plates for 20 hours was 123,000 
cells compared to the 100,000 cells found on the construct of the Tencell; this 
difference was not statistically significant (Figure 5-6). Low survival can be 
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Figure 5-3 Digital images of 70% porous POC scaffolds (A) before cell cultur 
preparation and (B) compared to a pH buffered scaffold characterised by the change of 
colour from white to pale yellow. POC scaffolds dimensions (C) and clamp marked area 
(D) are shown. Resultant constructs after cell culture in the TenceU with chang of 
colour caused by the culture medium (E) and clamp marks (F) 
1 1 
A 
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Clamp 
CoIlltruct 
~ I - - - - Media 
Chamber 
Figure 5-4Diagram of a TenceU chamber showing (A) lateral view of a construct held by 
one static clamp and by one mechanically coupled clamp. (B) Superior view of the 
chamber containing the construct surrounded by media. 
Figure 5-5 Digital image of HL-l/POC constructs (A) after 20 hours of tatic culture in 
the Tencell. (B) Constructs incubated in Alamar blue exhibit a change in colour from 
purplelblue to bright pink. Constructs in the central box were incubated in a plat 
whereas constructs in the discontinuous line box were in the Tencell. No m tabolic 
activity can be seen where the clamps were whilst the central constructs show metabolic 
activity through all the structure. 
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Figure 5-6 Survival of HL-l cells after 20 hours of static culture. Cells were seeded at two 
different concentrations, 55 x 103 cells and 110 x 103 cells per scaffold; and in two 
conditions: incubated in 8-well non tissue cultured plates or directly into the Tencell 
chambers. There was no statistical significant difference in the survival of any of th 
groups (mean ± SD, # indicates p > 0.05, n=3). However, when eeded at low r 
concentration, the overall survival was higher than seeded at higher concentration. 
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explained because the Tencell clamps held the construct in the chambers and 
therefore the adhesion area was reduced. 
Differences between initial seeding concentration were not significant. 
however when seeding at low concentration, survival was increased by 2 fold 
compared to the initial seeding concentration, whilst those seeded at higher 
concentration did not show the increase. This can be explained as a high 
concentration of cells may limit nutrients but also as an effect of the overall 
critical mass on the cell population dynamics. 
5.3.2 Survival after mechanical load 
Survival of constructs, as assessed by Alamar blue, was compared for static. 
continuously and discontinuously stretching conditions. Figure 5-7 shows the 
survival after 1 week with no significant difference between static and 
continuously loaded at 10% of amplitude and 1 Hz. This can be explained by 
the fact that the cells had no time to proliferate and differentiate due to 
mechanical strain. A significant difference was seen with discontinuous 
regimen, explained by cells bearing an intermittent load. Cyclic stretching of 
constructs allows a better nutrient and waste exchange through the constructs 
stretching and compressing the pores and by agitating the media. It has been 
established that strain forces also induce an autocrine/paracrine reaction in 
cardiac myocytes as biochemical factors are released into the media as 
demonstrated by Sadoshima and Izumo. They stretched 20% a set of constructs 
and then switched non-stimulated cells to the stimulated media resulting in a 
mimicked effect of stretch in the non-stretched cells. Mechanical stimulation at 
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Figure 5-7 Survival of HL-l cells after 1 week of culture in the Tencell cultured at 
different stretching regimen. There is a significant difference between survival in the 
Tencell static culture and the stretching for four hours per day but not between static 
and continuous culture (mean ± SD, *** indicates p<O.OOl , # indicates p>O.05, n=3) 
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this scale caused no cell injury as proved by the lack of lactate dehydrogenase 
or creatine kinase in the media [186]. Fink et at found that 3% of amplitude in 
the strain was the threshold above which the contractile force was developed in 
an engineered heart tissue [238]. Mechanical stimulation ranges between 3 and 
20% of strain for most of the in vitro studies reported. Akhyari et at stimulated 
cardiac grafts cyclically at 20% and 1.3 Hz and reported an increase in cell 
proliferation and distribution. Also the formation and organisation of the 
collagen matrix was superior when compared to the static control. After 14 
days in culture, the human paediatric cardiomyocyte-seeded collagen sponge 
exhibited increased strength, resistance to stretch and an aligned collagen 
matrix. This study confirmed that mechanical stimulation positively affects cell 
morphology, proliferation and ECM formation. [239]. Zhao et al stretched 
cardiomyocyte constructs at 10% at 2 Hz and found orientated bundles, 
terminal differentiation and synchronous beating [240]. Yu and Russell 
stimulated neonatal rat cardiomyocytes by also stretching the constructs at 
10% but at one, two, three and four hours. They found that there was a 
morphological change in the sarcomeres for all the conditions but the major 
difference was found after three hours of static strain [241]. Other groups have 
stretched at 20% of static strain finding induction of early genes causing 
hypertrophy in neonatal myocytes and hyperplasia in non-myocytes [188]. 
Tobita et al worked with embryonic cells in silicon constructs, and after 48 
hours of cyclic stretch at 4% and 8%, they found hyperplasia instead of 
hypertrophy demonstrating that the lack of proliferation in cardiac constructs is 
caused by the differentiated cardiomyocyte and not by the mechanical stimuli 
[242] 
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It has also been demonstrated that cells are reversibly deformed by stretching 
the substrate and sustain no cell injury or slippage from the substrate [174]. 
Although mechanical stimulation is not indispensable to obtain functional 
grafts as demonstrated by Huang et al who obtained a contractile 
"bioengineered heart muscle" by static culture using fibrin, it is desirable to 
mimic the native conditions [243]. Alternatively perfusion has been used to 
induce stress to cardiac constructs. Yang et al used a pulsatile flow system to 
mimic biomechanical signals [244] Park also investigated the perfusion system 
but at lower rate and found that this improved the cell survival because 
perfusion enhances mass transport in the interior of the construct [245]. 
The next step in mimicking the cardiac environment is the mechano-electrical 
stimulation. Radisic et al have already explored electrical stimulation using 
collagen sponges and stimulated cyclically 2 miliseconds at 5 V fcm finding 
cell alignment and coupling synchronous contractions [246]. 
5.3.3 Gene expression 
Quantitative real-time Polymerase Reaction Chain (PCR) is an accurate 
method to determine levels of specific DNA or RNA sequences in cell or 
tissue samples. The method consists of the quantification of a fluorescent 
signal produced during the amplification of the sequence by PCR technology 
[93]. Three genes were evaluated with monolayer HL-l cells on fibronectin-
coated TCP: myh6. actcl and nppa. However when processing the cDNA of 
the Tencell samples with the primers for myh6 (Myosin heavy chain) it 
appeared that the primers generated two products, probably because of splice 
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variants, and therefore the results were not reliable and hence not used (Figure 
5-8). Initially hprtl and rp132 were used as housekeeping genes but after 
analysing the qRT-PCR results, it was seen that the values for the hprtl gene 
were too disperse. When analysed the relative expression of the target genes, 
hprtl expressions were unreliable. Willems et al consider hprtl an unsuitable 
reference gene because of its instability as previously reported by Murphy and 
Polak [247-248]. Rp132 was used as the only housekeeping gene to normalise 
actcJ and nppa results as it was reported that the ribosomal protein family 
sequences are effective reference genes [249]. 
Although the graphics show a noteworthy up-regulation of actc 1 in both 
stretching regimes, and an intermediate up-regulation in the nppa, statistical 
analysis of the normalised results reported no statistically significant difference 
in the expression of actcJ and nppa when the constructs were stretched either 
continuously or discontinuously (Figure 5-8). Nevertheless, continuous 
stretching presented a greater expression of both genes when compared to the 
discontinuous regime. Previously Auluck et al reported that ECM remodelling 
was up-regulated dependant upon strain type, amplitude and frequency. This 
group evaluated myogenic cells seeded in gelfoams stimulated at 7.5% and 
15% amplitude. Constructs were evaluated under two stretching regimes: 
continuous for 6 hours or cyclic at 12 cycles/h for 6 hours. It was found that at 
greater amplitude and under continuous stretching, a greater response matrix-
metalloprotease 2 was induced [240] The up-regulation found in the Tencell 
coincides with Sadoshima et al who reported that skeletal alpha actin gene was 
up-regulated when cardiomyocytes were stretched in vitro. However they also 
mentioned that actin may not be the best marker for hypertrophy because it can 
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Figure 5-8 Melt curves of the primers for (A) hprtl, (B) rp132, (C) actc1, (D) myh6 and 
(E) nppa. Several peaks are observed in the myh6 melt curve indicating the 
amplification of additional sequences. 
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Figure 5-9 REST statistical analysis of actc1 and nppa in (A) continuously stretched and 
(B) discontinuously stretched normalised with rpl32 as housekeeping gene. Actc1 was up-
regulated in both cases, although a 4-fold up-regulation is observed in discontinuous 
regimen. No significant difference was found according to the statistical method (mean ± 
SD, # indicates p > 0.05, n::::;9) 
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be up-regulated even after the hyperplasia stadium in contrast to B-MHC and 
ANF which are stable late markers [184]. Mechanical stimulation is not the 
only cause of the up-regulation of these genes. Brown et al demonstrated up-
regulation of ANF when cardiomyocytes were cultured on a fibronectin-coated 
silicon surface; their findings suggest that gene expression is regulated by a 
remodelled ECM [228]. Komuro et al also found that the mechanical load 
applied to silicon constructs up-regulated gene transcription in vitro [251]. 
Authors agree that genes are up-regulated when cardiomyocytes are 
mechanically stimulated; nevertheless a down-regulation of actin expression 
has also been reported when cardiomyocytes were cultured in a dynamic 
bioreactor using a collagen matrix [252]. 
5.3.4 Protein expression 
Alpha-cardiac actin was stained to confirm the presence of protein indicated by 
the gene expression. The limited number of constructs per experiment only 
allowed for one protein to be stained. Figure 5-9 illustrates the presence of 
actin filaments in HL-l cells cultured in the Tencell bioreactor. No major 
differences were found between cells stretched discontinuously or 
continuously. 
5.3.5 Imaging of constructs 
Cell proliferation and differentiation were evaluated by staining for live cells. 
Unfortunately POC is an auto-fluorescent material in the red channel and 
therefore it is only possible to visualise live cells. After incubating in the 
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Figure 5-10 Fluorescent micrographs of actin filaments in HL-t cells stretched (A) 
discontinuously and (B) continuously loaded in the Tencell bioreactor. 
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Tencell the constructs, it was obvious that the clamped area did not support 
cell attachment or proliferation as can be seen in Figure 5-10. In the central 
areas of the construct, elongated cells were observed populating the POC 
scaffolds (Figure 5-11). No apparent difference was detected in cell 
distribution and morphology between continuous and discontinuously 
stretched samples when fluorescent images were analysed (Figure 5-12 and 5-
13). 
Figures 5-14 and 5-15 illustrate the cell distribution and differentiation of HL-
1 s in poe when visualised under the SEM. Cardiomyocytes statically cultured 
either on TCP or POC, presented clusters of dead cells but also areas of 
elongated cells organised into myofibres and aligned in the same direction. 
Constructs stretched continuously exhibited a larger area of dead cells whereas 
discontinuous stretched scaffolds shown fewer dead cells and an increased 
surface of organised elongated cells as can be seen in Figure 5-15. No major 
variation can be concluded from SEM images, although in this case SEM 
evaluated random areas and could not give a comprehensive analysis of the 
entire specimen due to the nature of the scaffold. 
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Figure 5-11 Composed image of fluorescent stereo-micrographs of a HL-IIPOC construct 
cultured in the Tencell stained for LivelDead. Non-fluorescent lateral areas correspond 
to the clamps that hold the construct in position and therefore no cell attachment nor 
proliferation is visible. 
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Figure 5-13 Fluorescent stereo-micrographs of HL-t constructs cultured (A, B) staticalIy, 
(C, D) under continuous mechanical load and (E,F) in a stretching regime of four hours 
per day 
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Figure 5-14 Confocal micrographs of "L-ls cultured (A,B) statically and (C.D) in the 
Tencell. 
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Control plate Control Tencell 
Figure 5-15 SEM microphotographs of POC constructs seeded with HL-1 cells and 
statically cultured for a week in a 8-well plate and in the Tencell. Continuous arrows 
indicate dead cells and discontinuous arrows show structures that resemble aligned 
myofibres. 
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Figure 5·16 SEM microphotographs of POC constructs seeded with HL·l cells and 
cultured for a week in the Tencell with continuous and discontinuous stretching regime. 
Continuous arrows indicate dead cells and discontinuous arrows show cardiomyocyte of 
typical phenotype. 
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5.4 Conclusions 
Barron et al reported that the use of bioreactors allowed the development of 
cardiac constructs by providing the conditions for a resultant graft with better 
morphological characteristics compared to static culture [243]. In this case this 
dynamic system did not produce a better construct overall. Mechanical 
stimulation did elicit an up-regulation of actcJ and nppa genes, although these 
findings coincide to what has been previously described by other groups, the 
variation in the results was considerably high and therefore the difference 
between the stretching regimes was not significant. However, these stretching 
regimes proved to impact the construct with an increased survival of the 
cardiomyocytes in the discontinuous regime compared to the survival of non-
stretched structures. It was also shown that cardiomyocytes attach, proliferate 
and exhibit their typical phenotype in poe scaffolds and survive in a dynamic 
environment. 
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6 General Discussion and Conclusions 
Cardiac diseases have been treated with cellular cardiomyoplasty and drugs as 
an alternative to the shortage of transplant organs. Cardiac tissue engineering 
seeks to offer an additional advantage to cellular cardiomyoplasty: the 
immediate functionality and the possibility to use the engineered cardiac 
muscle also as a screening technique and as an alternative to animal models. 
Cardiac tissue engineering has exploited the use of dynamic bioreactors to 
mimic the electro-mechanical environment of the heart. Mechanical stimuli 
have been proved to be of major relevance for cellular alignment and 
biochemical signalling when primary cardiomyocytes have been cultured onto 
flexible materials under these dynamic conditions; however, no work has been 
done using the HL-I cardiac cell line on the novel POC elastomer [183-186]. 
There is therefore the need to assess if the use of this polymer when culturing a 
cardiac cell line in a stretching regime could prove beneficial for cardiac tissue 
formation. 
The aims of this work were to culture HL-l slPOC constructs in the dynamic 
bioreactor Tencell and to assess the effect of mechanical stimulation under 
optimised parameters. Prior to this, it was considered the need to process and 
characterise POC scaffolds before modifying them to enhance cell adhesion. 
The first hypothesis was that POC could be processed into porous scaffolds 
suitable for cardiac tissue engineering. This work demonstrated that POC can 
be processed to create porous scaffolds using the salt leaching method but not 
by SCC02 processing as was thought. POC monomers resulted not solvent in 
CO2 and therefore the elastomer could not be foamed effectively. Porosity was 
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modified by altering the porogen concentration in the salt leaching method. 
The resulting scaffolds were characterised using SEM which allowed the 
qualitative analysis of the resulting scaffolds as well as the measurement of 
pore size. MicroCT provided pore size distribution and porosity as well as 
demonstrated pore connectivity and the effect of degradation overtime. Pore 
size correlated well between SEM and microCT measurements. 
Porosity and storage method significantly affected the mechanical properties of 
the scaffold. Solid POC ultimate elongation was previously reported at 260% 
with a Young's modulus of2.6 MPa [42]. In this study, POC porous structures 
only reached a Young's modulus of 3.3 kPa with 160% of ultimate elongation. 
Mechanical properties were proportionally weaker in scaffolds 70% and 80% 
porous when compared to those of 60% porous. It was also found that 
structures stored at low temperature exhibited a weaker Young's modulus than 
those stored at room temperature; however the ultimate elongation was higher 
as a result of a less stiff material. In addition to this, when the material was 
tested at high strain rates, the Young's modulus was higher than when the same 
material was evaluated at lower strain. This performance was explained as 
testing at low strain equals testing the material at low temperature, hence a 
stiffer behaviour. 
Incorporating cellulose to the scaffold improved the mechanical strength of the 
scaffolds with a Young's modulus of 13 kPa but the limited ultimate elongation 
(only 70%) in addition to the degradation profile of cellulose in the human 
body limited their use. Degradation profiles of 60%, 70% and 80% POC 
scaffolds showed no significant difference between these. All the scaffolds had 
a rapid initial degradation to then slow than and degrade totally by the 27th 
202 
week regardless the porosity. POC degradation profile would allow enough 
time to populate and support cell infiltration and proliferation and to degrade 
over time allowing the remodelling of the tissue with the newly produced 
ECM. 
Although POC is a hydrophilic polymer, it was expected to present poor cell 
adhesion because of its synthetic nature. Residual acidic monomers were also a 
concern due to its effect on pH. After assessing the mechanical properties, this 
material was evaluated for cell attachment and proliferation using the c2c 12 
and HL-I cell lines. Because of the low pH of the scaffolds when in aqueous 
media, it was needed to wash all the acid residues. 
The second hypothesis was that POC scaffolds could be modified to improve 
cell attachment. Results demonstrated that only when POC was modified with 
an ECM protein, cell adhesion was supported. Fibronectin, collagen and 
laminin were used to coat POC films at their optimal concentrations for 
myocytes and then evaluated for cell viability. In the results presented, 
fibronectin proved to be the most advantageous coating with nearly 90% of 
area coverage after 24 hours. Collagen and laminin did not provide the same 
biochemical cues and area coverage was minimal in surfaces coated with these 
compared to that of fibronectin. Because the use of proteins can present 
disadvantages on clinical applications, such as contamination, rejection and 
short-life, it may be considered to replace fibronectin with RGD before the 
construct goes into therapeutic stage [180]. ECM native proteins signal 
biological as well as mechanical stimuli. Ghosh et al demonstrated that cells on 
stiffer substrates exhibited higher elastic properties and cytoskeleton with more 
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stretched and organised actin filaments; cells on these also migrated and 
proliferated [254]. 
With respect to the effect of the porosity when seeding cardiomyocytes onto 
POC scaffolds, difference was not significant when cell survival was evaluated 
in 60%, 70% and 80% porous structures. Cells exhibited the same typical 
phenotype regardless the porosity used. The next step on biomaterial science is 
the design of "smart materials" which will respond to alterations in the local 
cellular environment such as temperature, acidity, enzymatic and biochemical 
signals. This response could vary from change in the biodegradation rate, 
release of active molecules or activation of specific factors [255]. 
The third hypothesis was that the seeding method would impact cell survival. 
Prior to dynamic culture in the stretching bioreactor, Tencell, seeding strategies 
were evaluated to determine the most suitable method for this system. Static, 
centrifugal and dynamical seeding was evaluated in c2c 12 and HL-l cells. 
Dynamic seeding has been used with more success with hydrophobic scaffolds 
to improve infiltration and contribute to a homogeneous seeding density; under 
these conditions, dynamic seeding usually increases viability and retention 
[174]. In the results presented, it was shown that static seeding proved to be the 
most beneficial seeding for these cells in 70% porous scaffolds, coated 
previously with fibronectin as determined in the previous studies. Centrifugal 
seeding, assessed in HL-I cells, was limited by the scaffold morphology. 
Dynamic seeding, carried out by shaking at 100, 200 and 300 rpm the 
constructs, showed that at low speed, cell survival and morphology are not too 
different from the static seeding; however after 24 hours of agitation at 200 and 
300 rpm, cells did not survive. Hence, it was concluded that no agitation or 
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minimal was required to ensure cell attachment and proliferation of myocytes 
in POC scaffolds. 
The last hypothesis was that mechanical stimulation would promote cardiac 
tissue formation. The use of bioreactors in tissue engineering is mainly 
because of the need of improve mass transfer; however in this case the 
bioreactor also allowed for the constructs to be mechanically stimulated. In 
terms of culturing the HL-l slPOC constructs in the Tencell, it was first 
demonstrated that there was no significant difference when the constructs were 
seeded in 8-well plates and later transferred to the bioreactor or when seeded in 
situ. Dynamic culture was compared as a regime of continuous stretching of 
10% of the construct against a discontinuous regime of 4 hours of mechanical 
stimulation at the same amplitude followed by 20 hours of static culture. After 
one week of dynamic culture, larger number of cells proliferated under 
discontinuous stretching compared to the other two conditions; cell viability 
was similar under static and continuous stretching. Constructs imaged by SEM, 
stereo and confocal microscopy revealed that HL-l s exhibited a typical 
phenotype when cultured statically and discontinuously but not so much when 
stretched continuously, where more dead cells were found. These results 
highlighted the importance of conditioning the cells without continuous 
stretching to allow the cells to attach and proliferate without mechanical strain. 
The effect of the mechanical stimuli in the constructs was also assessed at 
molecular level. Gene expression analysis of actcJ and nppa revealed an up-
regulation in both cases although no significant difference was obtained when 
comparing the continuous and the discontinuous regimes. It was thought that 
mechanical stimulation would provide an ideal environment for the 
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cardiomyocytes to form cardiac tissue; however results were not conclusive as 
not all the data was significantly better. Although cell survival was improved 
by discontinuous stretching, no myofibres formation was observed whilst up-
regulation of gene expression reached acceptable levels. 
In conclusion, POC scaffolds were characterised and modified for in vitro 
cardiac culture. In addition, cell imaging and biochemical assays have 
demonstrated that myocytes can attach, proliferate and exhibit their typical 
phenotype in POC scaffolds and survive in a dynamic environment. 
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INTRODUCTION: Recently cardiovascular 
diseases have become the main cause of death not 
only in the western countries but also in many 
developing countries [I]. Current research has 
concentrated on new alternatives such as cellular 
therapy. The lack of physical support containing 
growth factors to induce specific differentiation in 
the cellular therapy suggest that a cardiac construct 
could provide more clinical benefits if is able to 
supply such support. Cardiac muscle engineering is 
focused on obtaining cardiomyocyte constructs by 
seeding cardiac cells on suitable scaffolds. 
According to some works additional mechanical 
stimuli on cell culture systems have been shown to 
improve protein expression and differentiation in 
mammalian cells [2]. Our aim is to produce a 
flexible scaffold able to support mechanical load 
during tissue regeneration and evaluate the effects 
on the resulting 3D cardiomyocyte construct. 
METHODS: The elastomer Poly-( I ,8-octanediol-
co-citric acid) [POC] was processed to obtain a 
porous structure using the salt leaching method 
before it was completely cross linked, porosity was 
increased by modifying the sa lt concentration [3J. 
Porosity was evaluated with micro-tomography 
(!lCT) and scanning electron microscopy (SEM). 
POC films were precoated with Collagen type I, 
Fibronectin and Laminin at different concentrations 
to assess the effect on cell attachment and 
proliferation. The films were stored at room 
temperature in PBS and then seeded with a cardiac 
cell line, HL-l [4J . The monolayer cultures were 
evaluated for morphology, proliferation and 
survival. Also, 3D porous scaffolds were seeded 
with HL-I and the constructs evaluated for 
morphology, proliferation and survival. 
RESULTS: The scaffolds obtained from the POC 
polymer resulted flexible interconnected porous 
structures with a mean pore size of 350 !lm.!> suitable 
for cardiac tissue engineering (Figure I) . Data 
showed that unreacted monomers should be washed 
after the scaffold is processed to avoid a drop in the 
pH. Two--<limensional culture of HL-I cells on 
POC films showed an acceptable attachment to the 
surface, and this was improved in all the precoated 
films (Figure 2). 
Fig I: micro-tomography image (left) and SEM image 
(right) of a Poly- (l,8-octanediol-co-citric acid) 
[POC] scaffold 
Fig 2: HL-J cells after 24 hours of culture on poe 
film (left) and on poe film precoated with 
Fibronectin (right) 
DISCUSSION & CONCLUSIONS: POC is a 
biodegradable and flexible material that can be 
processed to obtain elastic porous scaffo lds suitable 
for cardiac engineering app lications. Cell cu lture on 
poe showed cell attachment but the modification of 
the surface by the protein coating improved ce ll 
adhesion, making it a suitable material for cardiac 
tissue engineering. The composition of the POC 
scaffold is being optimized to meet the mechanical 
and biological parameters needed for this purpose. 
Further research on the constructs cultured on other 
systems will be carried out to assess the impact of 
different cu lture conditions in this material. 
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